Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2014 Annual Meeting | Poster Session 06

Thursday 05/01/14
07:30 AM - 11:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology
No CME available
Event Timeline
07:30 AM - 11:00 AM Abstract 001 - Analyses Of Neural Autoantibodies By a Clinical Laboratory For The Evaluation Of Paraneoplastic And Non-Paraneoplastic Neuronal Disorders
Valerie Brachet, PhD
07:30 AM - 11:00 AM Abstract 002 - Cross-cultural comparison of stigma toward mental and neurological disorders
Laila Gharzai
07:30 AM - 11:00 AM Abstract 003 - Efficacy of Dalfampridine in Hereditary Spastic Paraplegia: a prospective open study
Nicolas Collongues, MD
07:30 AM - 11:00 AM Abstract 004 - Multidisciplinary Management of Cerebral Edema Associated with Fulminant Hepatic Encephalopathy in a Neurosciences Intensive Care Unit
Panayiotis N. Varelas, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 006 - Discharge Delays on an Inpatient Neurology Service
Ayush Batra, MD
07:30 AM - 11:00 AM Abstract 007 - Taking Neurology to the Underserved - A Pilot Initiative in an Urban Homebound Program
Ritesh Ramdhani, MD
07:30 AM - 11:00 AM Abstract 008 - Chronic inflammatory demyelinating polyneuropathy (CIDP) sera alter regulators of Schwann cell differentiation
Abhijeet R. Joshi
07:30 AM - 11:00 AM Abstract 009 - Methotrexate Induced Cerebellar Leukoencephalopathy
Christopher M. Goshgarian, MD
07:30 AM - 11:00 AM Abstract 010 - Subclinical primary Sjögren's Syndrome and associated peripheral neuropathy: optimizing diagnostic approach.
Etienne Laverse, MBBS, BSc, MRCP(Neurol), AICSM
07:30 AM - 11:00 AM Abstract 011 - Recurrent Stroke-like Events Preceding the X-linked Charcot-Marie-Tooth Disease Diagnosis
Tara Kimbason, MD, MPH
07:30 AM - 11:00 AM Abstract 012 - Abnormal white matter connectivity in children with autism or sensory processing disorder: overlap and divergence.
Elysa Marco, MD
07:30 AM - 11:00 AM Abstract 013 - An Abbreviated Exposure to Chronic Hypoxia is Sufficient to Induce CNS Hypomyelination and Impair Motor Development in Neonatal Mice
Jens Watzlawik
07:30 AM - 11:00 AM Abstract 014 - Infraslow Electroencephalography Changes in Infantile Spasms
Ken Myers, MD, PhD
07:30 AM - 11:00 AM Abstract 015 - Anti NMDA Receptor Encephalitis (ANMDARE): Outcome in a Cohort of 13 Children
Jay E. Selman, MD
07:30 AM - 11:00 AM Abstract 016 - Novel Mechanism for Monitoring Cerebral Hemodynamics in Pediatric ECMO
David R. Busch, PhD
07:30 AM - 11:00 AM Abstract 017 - Stiff Person Syndrome in Childhood: SPS-C Recognition and Review
Bennett L. Lavenstein, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 018 - A Rare Case of Microcephaly-Capillary Malformation Syndrome Diagnosed via Whole Exome Sequencing
Nassim Zecavati, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 019 - Does Duration of Steroid Treatment Matter in Pdiatric Optic Neuritis?
Himali R. Jayakody, MD
07:30 AM - 11:00 AM Abstract 020 - Functional Neurological Disorder In The Pediatric Emergency Room: Characteristics, Outcome And Diagnostic Accuracy
Claudio M. De Gusmao, MD
07:30 AM - 11:00 AM Abstract 021 - Postural Orthostatic Tachycardia Syndrome (POTS) and its associated symptoms
Anindita Deb, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 022 - Neurological Sequelae of Varicella Zoster Virus Infection ( VZV): Case Series of Varied Presentations
Shamaehah Javed, MD
07:30 AM - 11:00 AM Abstract 023 - Hashimoto's Encephalopathy Complicated by Cerebellar Ataxia: A Case Report
Michael Hossack, MD
07:30 AM - 11:00 AM Abstract 024 - Unusual Presentation of Acute Carbon Monoxide Poisoning
Shivnaveen Bains, MD
07:30 AM - 11:00 AM Abstract 025 - Dabigatran -The future of cortical venous thrombosis therapy -a case series study
Thomas Mathew, MD
07:30 AM - 11:00 AM Abstract 026 - Intrathecal Baclofen Toxicity Mimicking Nonconvulsive Status Epilepticus
Glynnis Zieman, MD, MPH, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 027 - Case Report: Uncommon Presentation of Neurosarcoidosis
Ikjae Lee, MD
07:30 AM - 11:00 AM Abstract 028 - Central Pontine and Extrapontine Myelinolysis: Risk Factors and Clinical Expression in Liver Transplanted Patients
07:30 AM - 11:00 AM Abstract 029 - Unusual Case of Delayed Postpartum Preeclampsia Associated with Reversible Splenial Lesion Syndrome
Pedro S. Oliveira, MD
07:30 AM - 11:00 AM Abstract 030 - Hypercholesterolemia and Neurological Diseases Related Mortality in the NEDICES Cohort
07:30 AM - 11:00 AM Abstract 031 - Atypical Presentation of Posterior Reversible Encephalopathy Syndrome
Annapoorna Bhat, MD
07:30 AM - 11:00 AM Abstract 032 - Neurological Disorders In Rosai-Dorfman Disease
07:30 AM - 11:00 AM Abstract 034 - The Need for Repeat Diagnostic Testing for the Identification of Ovarian Pathology in a Patient with anti-NMDA Receptor Limbic Encephalitis
Mona Bahouth, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 035 - Quality Improvement: Maintaining an Accurate Medication List by Standardizing the Outpatient Medication Reconciliation Method
Christina M. Nguyen, MD
07:30 AM - 11:00 AM Abstract 036 - Guillain-Barre in a Small Illinois Community: An Epidemiology Perspective
07:30 AM - 11:00 AM Abstract 037 - The Epidemiology of Neuromyelitis Optica at a City Hospital in the Bronx, New York
Sylvia A. Mohen, MD
07:30 AM - 11:00 AM Abstract 038 - Symptomatic Vitamin D deficiency in Dubai
07:30 AM - 11:00 AM Abstract 039 - Hyperkalemic Periodic Paralysis Masquerading as Sleep Paralysis
Yelena G. Pyatkevich, MD
07:30 AM - 11:00 AM Abstract 040 - POEMS syndrome associated with autoimmune limbic encephalitis, an unusual occurrence
Niraj A. Arora, MD
07:30 AM - 11:00 AM Abstract 041 - Neuroscience Â鶹´«Ã½Ó³»­ in the Medical College: The Qatar Experience
Leopold J. Streletz, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 042 - Posterior Reversible Encephalopathy Syndrome and Guillain - Barre Syndrome in a Pregnant Lady: A Case Report From A Tertiary Teaching Hospital Of South India
Dhairyawan Pokalkar, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 043 - Spinal Cord damage in Machado-Joseph disease
07:30 AM - 11:00 AM Abstract 044 - The Evaluation of Swallowing in patients with Spinocerebellar Ataxia and Oropharyngeal Dysphagia: a comparison study of Videofluoroscopic and Sonar Doppler
07:30 AM - 11:00 AM Abstract 045 - Polysomnographic findings in Machado-Joseph disease: evaluation of 47 patients
Jose Luiz Pedroso, MD
07:30 AM - 11:00 AM Abstract 046 - De Novo Deletion of AFG3L2 Causing Spinocerebellar Ataxia Type 28 in the Context of Multiple Genomic Anomalies
Ken Myers, MD, PhD
07:30 AM - 11:00 AM Abstract 047 - Coenzyme Q10, Statin, and Spinocerebellar Ataxias
Sheng-Han Kuo, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 048 - Audiological Evaluation in Spinocerebelar Ataxia
Helio Afonso G. Teive, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 049 - Wide Spectrum of Clinical Presentation of Spinocerebellar Ataxia Type 2
Shilpa Kolli
07:30 AM - 11:00 AM Abstract 050 - Widespread Cerebral Cortical Damage in Machado-Joseph Disease
07:30 AM - 11:00 AM Abstract 051 - Dystonia In Machado-Joseph Disease: Clinical Features And Levodopa Response
07:30 AM - 11:00 AM Abstract 052 - Treatment of Spinocerebellar Ataxia with Intravenous Immune Globulin (IVIG)
Theresa A. Zesiewicz, MD
07:30 AM - 11:00 AM Abstract 053 - Paroxysmal Dysarthria and Ataxia after Treatment of Brainstem Encephalitis
James P. Klaas, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 054 - Sporadic Cerebellar GAD-Ataxia: A Retrospective Analysis
Pezhman Roohani, MD
07:30 AM - 11:00 AM Abstract 055 - Elevated Thyroid Antibody Associated Sporadic Cerebellar Ataxia: A Retrospective Analysis
Pezhman Roohani, MD
07:30 AM - 11:00 AM Abstract 056 - Autoimmune Cerebellar Degeneration with Voltage Gated Calcium Channel Antibodies: A Case Report and Study of Antibody Reactivity
Marilyn J. McKasson, MD
07:30 AM - 11:00 AM Abstract 057 - Cerebellar ataxia with CoQ10 deficiency due to a novel mutation in ADCK3
Emanuele Barca, MD, PhD
07:30 AM - 11:00 AM Abstract 058 - A novel spinocerebellar ataxia with hematologic cytopenias: linkage analysis and exome sequencing identifies a candidate gene
Dong-Hui Chen, MD, PhD
07:30 AM - 11:00 AM Abstract 059 - iPatax: A new method for quantitative assessment for motor coordination of ataxia
Masayoshi Tada, MD, PhD
07:30 AM - 11:00 AM Abstract 061 - Spinocerebellar Ataxias with Hypogonadism: Unraveling a Novel Group of Inherited Neurometabolic Disorders
Charles M. Lourenco, MD, PhD
07:30 AM - 11:00 AM Abstract 062 - The use of Adjustments to facilitate the written in patients diagnosed with Spinocerebellar Ataxia
07:30 AM - 11:00 AM Abstract 063 - Cognitive Associations of White Matter Hyperintensities in Non-Demented Parkinson's Disease Patients: A Voxel-Wise Lesion Probability Study
Elijah Mak
07:30 AM - 11:00 AM Abstract 064 - A Longitudinal [11C](±)dihydrotetrabenazine PET Study of Gender Difference in the Progression of Dopaminergic Dysfunction in the Parkinsonian Caudate
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FANA, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 066 - Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease
Gaetan Garraux, MD
07:30 AM - 11:00 AM Abstract 067 - Subcortical atrophy is associated with cognitive impairment in mild Parkinson's disease: a combined volumetric and vertex-based shape analysis study
07:30 AM - 11:00 AM Abstract 068 - Cerebellar Atrophy in Patients with Parkinson's Disease Using the SUIT tool for Voxel-Based Morphometry
07:30 AM - 11:00 AM Abstract 069 - Quantitative MRI Biomarker Study in Parkinson's Disease: High-field 1H-MR Spectroscopic and Multi-Modal MRI Longitudinal Study of the Substantia Nigra
Navid Seraji-Bozorgzad, MD
07:30 AM - 11:00 AM Abstract 070 - Accuracy and diagnosis cutoff points of 123I-metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease diagnoses in parkinsonian syndromes: a study of 62 consecutive patients in an expert center.
Guillaume Lamotte, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 071 - Multi-Modal High-Field MRI Longitudinal Study of the Deep Gray Matter, Frontal Lobe, and Corpus Callosum in Parkinson's Disease.
07:30 AM - 11:00 AM Abstract 073 - Stimulating Frontostriatal Circuitry to Treat Motor and Non-Motor Symptoms of Parkinson's Disease
Nolan Williams, MD
07:30 AM - 11:00 AM Abstract 074 - Tinnitus after Deep Brain Stimulation Surgery, a Case Series
Umer Akbar, MD
07:30 AM - 11:00 AM Abstract 075 - Clinical Manifestations of Tolerance to Deep Brain Stimulation
Deepal P. Shah-Zamora, MD
07:30 AM - 11:00 AM Abstract 076 - Use of Interleaving in Deep Brain Stimulator Programming in Patients with Movement Disorders
Joohi Jimenez Shahed, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 077 - Clinical significance of abnormal electrode impedance readings in deep brain stimulation for treatment of movement disorders
Olga Waln, MD
07:30 AM - 11:00 AM Abstract 078 - A Case of Dystonic Head Tremor treated with Bilateral Globus Pallidus pars Interna Deep Brain Stimulation
Joanna E. O'Leary, MD
07:30 AM - 11:00 AM Abstract 079 - Parkinson's disease is associated with enhanced pain-related disability and the selective loss of gray matter in subcortical regions of the brain related to pain processing
Andrew H. Ahn, MD, PhD
07:30 AM - 11:00 AM Abstract 080 - Effect of laterality in Parkinson`s disease: a Voxel-based Morphometry Study
Maria Cristina Arci Santos
07:30 AM - 11:00 AM Abstract 081 - [18F]FDG PET, [18F]FP-CIT PET and MR Morphometry in Lewy body Dementia: Comparison with Alzheimer disease
Hyunjin Kim, MD
07:30 AM - 11:00 AM Abstract 083 - High Resolution Ultrasound in Combat-Related Peripheral Nerve Injuries: A Case Series
Jonathan K. Smith, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 084 - Accuracy of Ultrasound for Diagnosis of Carpal Tunnel Syndrome in Patients with Bifid Median Nerve
Jonathan M. Beary, DO, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 085 - Distinctive Patterns of Sonographic Nerve Enlargement in Charcot-Marie-Tooth type 1A and Hereditary Neuropathy with Pressure Palsies.
Stephan Goedee, MD
07:30 AM - 11:00 AM Abstract 086 - Peripheral Nerve Ultrasound in Small Fiber Neuropathy
Hamid Ebadi, MD
07:30 AM - 11:00 AM Abstract 087 - Neuromuscular Ultrasound Findings in Eosinophilic Fasciitis
Sarah Stone, MD
07:30 AM - 11:00 AM Abstract 088 - The Value of Including Sweat Gland Nerve Fiber Density (SGNFD) Analysis in the Neuropathy Work-up
Amiram Katz, MD
07:30 AM - 11:00 AM Abstract 089 - 99mTc-DPD Cardiac Scintigraphy in Familiar Amyloidosis
07:30 AM - 11:00 AM Abstract 090 - Blood pressure dipping during the deep breathing maneuver (BPDB) while supine may be a marker of severe sympathetic denervation
Alexandru C. Barboi, MD
07:30 AM - 11:00 AM Abstract 091 - Increased Frequency of Rhabdomyolysis in Familial Dysautonomia
07:30 AM - 11:00 AM Abstract 092 - Subacute Onset of Severe Cidp Weakness Associated With Tumor-Like Nerve Root Involvement: A Case Report
Sharon Stoll, DO
07:30 AM - 11:00 AM Abstract 093 - Peripheral Neuropathy (PN) in Individuals with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibromas (PNF)
Tanya J. Lehky, MD
07:30 AM - 11:00 AM Abstract 094 - Evaluation of Central and Peripheral Neuropathy in Type 2 Diabetes: A Case-Control Study
Prasanna Venkatesan Eswaradass, MD
07:30 AM - 11:00 AM Abstract 095 - Idiopathic Peripheral Neuropathy and Subsequent Development of Diabetes Mellitus
Ritika Mahajan, MD
07:30 AM - 11:00 AM Abstract 096 - Opioid Usage in Peripheral Neuropathy: A Population-Based Study
E. M. Hoffman, DO, PhD
07:30 AM - 11:00 AM Abstract 097 - Reference Attributes of Nerve Conduction and Ethnicity: Comparison in Northern Plain Indians, Mexican Americans and Caucasians
Rajat Lahoria, MD
07:30 AM - 11:00 AM Abstract 098 - A Population-Based Epidemiologic Study of Adult Neuromuscular Disease in the Republic of Ireland
Stela Lefter, MD
07:30 AM - 11:00 AM Abstract 099 - Trends in Outcome and Cost of Hospitalization of Elderly Myasthenia Gravis Patients Treated with Plasmapheresis from 1992 to 2009
Mohammad H. El-Ghanem, MD
07:30 AM - 11:00 AM Abstract 100 - Emerging Epidemiological Trends of Autoimmune Myasthenia Gravis in Connecticut
Matthew Imperioli, MD
07:30 AM - 11:00 AM Abstract 101 - “Fainting in teenagers is not always Faking”
Sreenivas Avula, MD
07:30 AM - 11:00 AM Abstract 102 - CNS Toxoplasmosis: A serious complication of immunotherapy in the neuromuscular patient
Danilo Bernardo, MD
07:30 AM - 11:00 AM Abstract 103 - Fingolimod (FTY720) Oral For The Treatment Of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Study Design Of The Phase 3 FORCIDP Trial
Hans-Peter Hartung, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 104 - Characteristics of Muscle Cramps in Patients with Polyneuropathy
Hans D. Katzberg, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 105 - Electrodiagnostic Profile of Demyelination in Diabetic Neuropathy: A novel approach
Zubeda B. Sheikh, MD
07:30 AM - 11:00 AM Abstract 106 - West Nile Virus Encephalomyelityis Simulating Brain Death
Channaiah Srikanth Mysore
07:30 AM - 11:00 AM Abstract 107 - Zoster Associated Limb Paresis (ZALP) is Associated with Prolonged Weakness and Pain: A Natural History Study
Alex Nelson, MD
07:30 AM - 11:00 AM Abstract 108 - Branching Enzyme Deficiency: Expanding The Clinical Spectrum
07:30 AM - 11:00 AM Abstract 109 - Oxidative Metabolism During Forearm Exercise in McArdle disease
Ronald G. Haller, MD
07:30 AM - 11:00 AM Abstract 110 - The Pattern of Pain in Carpal Tunnel Syndrome Follows a Bell-shaped Curve
Benn E. Smith, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 111 - When expected turns unexpected: A case of subacute progressive weakness and paresthesias of the distal lower extremities following a brief diarrheal episode.
Divpreet Kaur, MD
07:30 AM - 11:00 AM Abstract 112 - Clinical Impact of Brain Tissue Damage quantified by fully automated analysis of MR Images in patients with Multiple Sclerosis
Alaleh Raji, MD
07:30 AM - 11:00 AM Abstract 113 - Sub-optimal Response to Therapy in Disease-free MS Patients: A Paradox?
Fernando F. Figueira, MD
07:30 AM - 11:00 AM Abstract 114 - Longitudinal effects of interferon-beta-1a treatment on cortical thickness in relapsing-remitting multiple sclerosis patients
Anat Achiron, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 115 - Associations Between Changes in Ferritin Levels and Susceptibility-Weighted Imaging Filtered Phase in Patients with Relapsing-Remitting Multiple Sclerosis over Six Months Therapy with Interferon Beta-1a
Michael G. Dwyer III, MD, PhD
07:30 AM - 11:00 AM Abstract 116 - Evolution of Corpus Callosum Index in Patients with Relapsing Remiting Multiple Sclerosis Treated with Natalizumab
Eva Costa Arpin, MD
07:30 AM - 11:00 AM Abstract 117 - Corpus Callosum Volume Change in the First Year is the Strongest Predictor of 9-year Clinical Disability in Multiple Sclerosis
Dana Horakova
07:30 AM - 11:00 AM Abstract 118 - A new composite scale of MRI-defined disease severity in multiple sclerosis
Mohit Neema, MD
07:30 AM - 11:00 AM Abstract 119 - Fully automated Detection and Quantification of T1 hypointense lesions in Multiple Sclerosis
Alaleh Raji, MD
07:30 AM - 11:00 AM Abstract 120 - Cerebellar and Brain Gray-Matter Damage Predicts Fatigue in Multiple Sclerosis
Alfredo Damasceno, MD
07:30 AM - 11:00 AM Abstract 121 - Abnormal White Matter fraction predicts cognitive dysfunction in Multiple Sclerosis patients
Manuela De Stefano
07:30 AM - 11:00 AM Abstract 122 - Diffusional Kurtosis MRI Correlates Of Cognitive Functions In Primary-Progressive MS
Maria Petracca, PhD
07:30 AM - 11:00 AM Abstract 123 - Functional Correlates of Impaired Working Memory in MS Patients: A Multicentre Study
Alvino Bisecco
07:30 AM - 11:00 AM Abstract 124 - Cognitive Reserve in Multiple Sclerosis Modulates Hippocampal Functional Connectivity and Protects from Memory Deficits
Maria A. Rocca
07:30 AM - 11:00 AM Abstract 125 - Iron In The Deep Gray Matter: Association With Cognitive Impairment In Multiple Sclerosis
Claire Modica
07:30 AM - 11:00 AM Abstract 126 - Brain White Matter Tract Microstructural Alterations in Multiple Sclerosis Patients with Depression and Fatigue: A Diffusion Tensor MRI Study
Gianna Carla Riccitelli
07:30 AM - 11:00 AM Abstract 127 - Contribution of Global and Regional Damage of the Gray and White Matter to Fatigue in MS
07:30 AM - 11:00 AM Abstract 128 - Network efficiency as a final common pathway for cognitive deficits in multiple sclerosis: a single network graph theory study
Matteo Pardini, MD, PhD
07:30 AM - 11:00 AM Abstract 129 - Microstructural Damage to NAWM and GM but Not to Cortical Lesions Contributes to Cognitive Impairment in Multiple Sclerosis: A Diffusion Tensor MRI Study
07:30 AM - 11:00 AM Abstract 130 - Patterns of Regional Gray Matter and White Matter Atrophy in “Cortical Multiple Sclerosis”
07:30 AM - 11:00 AM Abstract 131 - The rate of new GM lesion development is similar in all MS disease subtypes
Rasha Abdel-Fahim
07:30 AM - 11:00 AM Abstract 132 - Global and Regional Brain Concentration of Intra- and Extra-cellular Sodium in MS: A 7 Tesla MRI Study
07:30 AM - 11:00 AM Abstract 133 - Accrual and evolution of cortical gray matter lesions in people with relapse-onset multiple sclerosis
Varun Sethi, MD, PhD
07:30 AM - 11:00 AM Abstract 134 - MRI-Based Detection and Characterization of Leptomeningeal Contrast Enhancement in Multiple Sclerosis
Luisa Vuolo
07:30 AM - 11:00 AM Abstract 135 - The Use of BigBrain in MS: An Ultrahigh-resolution 3D Template for Grey Matter MRI Segmentation
07:30 AM - 11:00 AM Abstract 136 - A Robust and Fast Algorithm for Quantifying Spinal Cord Cross-sectional Area in Myelitis
Govind Bhagavatheeshwaran
07:30 AM - 11:00 AM Abstract 137 - Relationship between Spinal Cord Atrophy and Brain Cortical Lesions in Primary-Progressive MS
07:30 AM - 11:00 AM Abstract 138 - The Neurofunctional Basis of Sensorimotor Preservation in Multiple Sclerosis
Victoria Leavitt, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 139 - Normal appearing white matter injury in MS is affected by the distance to the nearest cortical lesion
Nikolaos Evangelou, PhD
07:30 AM - 11:00 AM Abstract 140 - Level of Homocysteine, Homocysteine Thiolactone and Antibodies against N-homocysteinylated Proteins in Patients with Multiple Sclerosis
Justin Murphy, MD
07:30 AM - 11:00 AM Abstract 141 - Smoking Cessation and Disability Progression in Multiple Sclerosis: an Observational Cohort Study
Cris S. Constantinescu, MD, PhD
07:30 AM - 11:00 AM Abstract 142 - Serum Lipid and Antiphospholipid Antibodies Profiles in Different Phases of Multiple Sclerosis
Tatiana Koudriavtseva, MD
07:30 AM - 11:00 AM Abstract 143 - Multiple Sclerosis and Premorbid Risk Behaviour: Association Is Not Necessarily Causation
Christopher H. Hawkes, MD, Bsc, FRCP, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 144 - Vitamin D and Multiple Sclerosis: Are We Still in the Dark?
Michael Douglas, MD
07:30 AM - 11:00 AM Abstract 145 - Vitamin D Deficiency in Multiple Sclerosis: Possible Influence of Circulating Vitamin D Binding Protein Levels.
Suhail Al-Shammri, FRCPC, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 146 - Modulating effects of WT1 on the relationship between interferon-? and vitamin D levels in the patients with multiple sclerosis
07:30 AM - 11:00 AM Abstract 147 - The Role of Vitamin D in Optic Neuritis - An Update
Jodie Burton, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 148 - Vitamin D, B-Cell Immunoreactivity, and B-Cell Phenotypes in Cerebrospinal Fluid of Patients with Multiple Sclerosis
Brigitte Wildemann, MD
07:30 AM - 11:00 AM Abstract 149 - Dietary saturated fatty acids promote differentiation of Th1 and Th17 cells and aggravate neuroinflammation
07:30 AM - 11:00 AM Abstract 150 - Sodium intake is associated with increased disease activity in multiple sclerosis
Mauricio F. Farez, MD
07:30 AM - 11:00 AM Abstract 151 - Identification of Clostridium perfringens epsilon toxin as a candidate trigger for new lesion formation in Multiple Sclerosis
Timothy K. Vartanian, MD, PhD
07:30 AM - 11:00 AM Abstract 152 - Effects of a Low Fat Plant Based Diet in Multiple Sclerosis (MS): Results of a 1- Year Long Randomized Controlled (RC) Study
Vijayshree Yadav, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 153 - Expression of Multiple Sclerosis Susceptible Loci genes may assist in Diagnostic Decision Making
Michael Gurevich
07:30 AM - 11:00 AM Abstract 154 - A Multiple Sclerosis-associated single nucleotide polymorphism in the MERTK receptor is correlated with altered MERTK expression
Trevor J. Kilpatrick, MBBS, PhD
07:30 AM - 11:00 AM Abstract 155 - Is it worth to study families with Multiple Sclerosis (MS)? The case of a novel rare variant in a novel unexpected interferon-stimulated gene.
Filippo Martinelli Boneschi
07:30 AM - 11:00 AM Abstract 156 - CD58 and multiple sclerosis: genetic association, gene expression and prognostic value
Michael Hecker, PhD
07:30 AM - 11:00 AM Abstract 157 - An analysis of novel antibody repertoires in patients with Multiple Sclerosis: Do particular antibody genes recognize gray matter cellular targets?
Ann Ligocki
07:30 AM - 11:00 AM Abstract 158 - Molecular Network of ChIP-Seq-Based EBNA1-Target Cellular Genes Supports Biological Implications of EBV Persistence in Multiple Sclerosis
Jun-ichi Satoh, MD, PhD
07:30 AM - 11:00 AM Abstract 159 - Gustatory Dysfunction in Multiple Sclerosis
Richard L. Doty, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 160 - Multiple Sclerosis Reported Fatigue: Obstructive Sleep Apnea & Abnormalities in Sleep Architecture in a Community Cohort
Mark Gudesblatt, MD
07:30 AM - 11:00 AM Abstract 161 - Visual Field Defects in Multiple Sclerosis and Related Disorders
Dong Joo Yun
07:30 AM - 11:00 AM Abstract 162 - Multiple Sclerosis Exacerbation Presenting as Stress Cardiomyopathy
Tyler Webb, MD
07:30 AM - 11:00 AM Abstract 163 - Headache in Multiple Sclerosis: Features and Implications for Disease Management
Jessica Wilcox, MD
07:30 AM - 11:00 AM Abstract 164 - Neuropathic Pain in Multiple Sclerosis: a Contact Heat Evoked Potential Stimulator (CHEPS) Evaluation
07:30 AM - 11:00 AM Abstract 166 - Multiple Sclerosis Compromises Various Aspects of Female Sexual Function
Julia Koehn, MD
07:30 AM - 11:00 AM Abstract 167 - Head-Up Tilt Test, R-R Interval Variation and Sympathetic Skin Response in the Assessment of the Autonomic Nervous System of Patients With Multiple Sclerosis
Hizir Ulvi, MD
07:30 AM - 11:00 AM Abstract 168 - Metabolic Syndrome and Disability in Multiple Sclerosis: A Retrospective Study
Idanis Berrios Morales, MD
07:30 AM - 11:00 AM Abstract 169 - Multiple Sclerosis and Stroke
Eleanor Sung
07:30 AM - 11:00 AM Abstract 170 - Prevalence of Thyroid Disease in a Multiple Sclerosis Clinic Cohort
Donald A. Barone, DO
07:30 AM - 11:00 AM Abstract 171 - A study of insulin resistance in multiplesclerosis subjects and healthy controls
Myla D. Goldman, MD, MSc, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 172 - Multiple Sclerosis Patients with Allergies Demonstrate Better Physical Outcomes but Worse Psychological Symptoms.
Sahil Gupta, MD
07:30 AM - 11:00 AM Abstract 173 - Right under our noses: olfactory pathology in central nervous system demyelinating diseases
Gabriele C. De Luca, MD, DPhil, FRCPath, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 174 - Deterioration or Improvement of Depression in Women is Associated with Site and Size of Multiple Sclerosis Lesions
Klemens Winder, MD
07:30 AM - 11:00 AM Abstract 175 - Functional Limitations Associated with Multiple Sclerosis: Findings from the US Medical Expenditure Panel Survey
Joseph Menzin, PhD
07:30 AM - 11:00 AM Abstract 176 - Increased Incidence of Breast Cancer in Multiple Sclerosis: The Influence of Vitamin D and Estrogen in MS-Breast Cancer Concordance
Jacquelyn Laplant
07:30 AM - 11:00 AM Abstract 177 - Smoking in Multiple Sclerosis Patients is Negatively Associated with Patient Perceived Psychosocial Factors
07:30 AM - 11:00 AM Abstract 178 - Risk of Mood Changes with High Dose Corticosteroid Treatment for Demyelinating Event in Multiple Sclerosis
Sarah A. Morrow, MD, MSC, FRCPC, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 179 - Patient and Caregiver Quality of Life in Psychogenic Non-Epileptic Seizures Compared to Epileptic Seizures
Ioannis Karakis, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 180 - Impact of Seizure Frequency Reduction on Health-Related Quality of Life Among Clinical Trial Subjects with Refractory Partial-Onset Seizures: A Pooled Analysis of Phase III Clinical Trials of Eslicarbazepine Acetate
07:30 AM - 11:00 AM Abstract 182 - STOP-BANG Screening for Obstructive Sleep Apnea in Epilepsy
Joon Y. Kang, MD
07:30 AM - 11:00 AM Abstract 183 - Effects of Lacosamide on Sleep Parameters in Healthy Subjects: Results from an Open-label Study
07:30 AM - 11:00 AM Abstract 184 - Systematic Review of the Impact of Rapid Eye Movement Sleep on Seizure Frequency
Marcus Ng, MD
07:30 AM - 11:00 AM Abstract 185 - Do antidepressants make seizures more or less likely in focal epilepsy patients undergoing elective EEG monitoring?
Alyssa Brandt
07:30 AM - 11:00 AM Abstract 186 - Does Vitamin D Use Alter Seizure Collections During Elective Adult Inpatient Video EEG Monitering?
Alyssa Brandt
07:30 AM - 11:00 AM Abstract 187 - Prevalence Of Metabolic Syndrome In Valproate-Treated Adult Patients With Epilepsy
Aleksei Rakitin, MD
07:30 AM - 11:00 AM Abstract 189 - The Effect of Valproate and Lamotrigine Monotherapy on Bone Health in Adult Epileptic Patients
Mohammad S. Alhalabi, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 190 - Response-driven Models based on MRI and SPECT findings on Hippocampus for Lateralization of Temporal Lobe Epilepsy
07:30 AM - 11:00 AM Abstract 192 - Magnetic Resonance Grading of Hippocampal Sclerosis in Temporal Lobe Epilepsy Patients Using an Equilibrium Model
07:30 AM - 11:00 AM Abstract 193 - Cerebral Hyperperfusion and Vasodilatory Changes in Acute Seizure - Report of Three Cases
Balaji Krishnaiah, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 194 - Quantitative Analyses of EEG with Special Electrodes in TGA Patients
07:30 AM - 11:00 AM Abstract 196 - Is presurgical MEG useful in intractable temporal lobe epilepsy?
07:30 AM - 11:00 AM Abstract 197 - Validation of Magnetoencephalography (MEG) as Presurgical Evaluaiton Tool in Pediatric Patients With Localization-Related Intractable Epilepsy.
Helen Barkan, MD, PhD
07:30 AM - 11:00 AM Abstract 198 - Comparison of Diagnostic Methods for Optimizing Epilepsy Surgery Outcome Including Magnetoencephalography
William Boles, MD
07:30 AM - 11:00 AM Abstract 199 - Circle of Willis, cerebral blood flow, and white matter hyperintensities in migraine
Brett L. Cucchiara, MD
07:30 AM - 11:00 AM Abstract 200 - F MRI analysis in Chronic Migraine: preliminary report
Licia Grazzi, MD
07:30 AM - 11:00 AM Abstract 201 - White Matter Microstructure Abnormalities in Paediatric Migraine Patients: In-Vivo Measures of Brain Hyperexcitability?
07:30 AM - 11:00 AM Abstract 203 - Mid-Life Migraine and Late-Life Movement Disorder Symptoms: AGES-Reykjavik Study
Ann Scher, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 204 - Does the new International Classification of Headache Disorders will affect the Prevalence of Aura in patients with Migraine ?
Hossein Ansari, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 205 - Barriers to Chronic Migraine Care: Results of the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study
Dawn C. Buse, PhD
07:30 AM - 11:00 AM Abstract 206 - Association of the long pentraxin PTX3 gene polymorphism (rs3815627) with migraine in Iranian population
Alireza Zandifar, MD
07:30 AM - 11:00 AM Abstract 207 - Sinking Bone Flap Causing Paradoxical Orthostatic Headaches
Mitra Assadi Khansare, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 208 - Investigation of Chemokine Receptor CCR2V64Il Gene Polymorphism and Migraine in Iranian Population
Alireza Zandifar, MD
07:30 AM - 11:00 AM Abstract 209 - Idiopathic Intracerebral Hypertension (IIH)/pseudotumor: Removing less CSF is best
07:30 AM - 11:00 AM Abstract 210 - Peri Ictal Headache In Epilepsy
Natarajan Visvanathan, MD, DM, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 211 - Validating a Definition of Alcohol Sensitivity in Women with Migraine
Qinyi Jiang
07:30 AM - 11:00 AM Abstract 212 - Retrospective analysis of the predictors of successful posterior fossa decompression in patients with headaches attributed to chiari malformation
Naresh Mullaguri, MD
07:30 AM - 11:00 AM Abstract 213 - A Nutrition Intervention for Migraines
Anne E. Bunner, PhD
07:30 AM - 11:00 AM Abstract 214 - Individualized Pharmacogenetic Testing Improves Mood and Anxiety Treatment Outcomes in Chronic Migraine Patients
Sandeep Vaishnavi, MD, PhD
07:30 AM - 11:00 AM Abstract 215 - A Live Patient Simulation Model to Effectively Manage Difficult Headache Patients
Fermina A. Pirmohamed, MD
07:30 AM - 11:00 AM Abstract 216 - Chronic Migraine with Medication Overuse is Associated with Low Cognitive Reserve
07:30 AM - 11:00 AM Abstract 217 - Bilateral Pain Hypersensitivity Over The Trigeminal Region And Dental Deafferentations In Patients With Classical Trigeminal Neuralgia
Nathalie Guy Renouil, MD
07:30 AM - 11:00 AM Abstract 218 - Diffusion Tensor Imaging in PSEN1-Related Spastic Paraparesis Reveals Widespread White Matter Abnormalities
07:30 AM - 11:00 AM Abstract 219 - Shared Vulnerability of Two Synaptically-Connected Medial Temporal Areas to Age and Cognitive Decline: A 7T MRI Study
Geoffrey A. Kerchner, MD, PhD
07:30 AM - 11:00 AM Abstract 220 - White Matter Disease in Behavioral Variant Frontotemporal Dementia Correlates with Risk-Taking Behavior
John Powers
07:30 AM - 11:00 AM Abstract 221 - The Symmetric And Asymmetric Variant Of Microvascular White Matter Disease
07:30 AM - 11:00 AM Abstract 222 - Voxel-based Morphometry Reveals Gray Matter Loss in Patients with Paget's Disease of the Bone Carrying SQSTM1 Gene Mutations
Innocenzo Rainero, MD, PhD
07:30 AM - 11:00 AM Abstract 223 - Regional Brain Differences in Cortical Thickness between Patients with Amnesic Mild Cognitive Impairment and Alzheimer`s Disease Dementia
Ignacio Demey, MD, PhD
07:30 AM - 11:00 AM Abstract 224 - Hippocampal Subfield Analysis in MCI patients: Comparing FreeSurfer on 3T MRI with Hand Segmentation on 7T Data
Salil Soman, MD
07:30 AM - 11:00 AM Abstract 225 - Functional Language Lateralization Of Primary Progressive Aphasia Variants
Zachary Miller, MD
07:30 AM - 11:00 AM Abstract 226 - A Cross-Culturally Valid Assessment of Object Semantics
Bonnie Breining
07:30 AM - 11:00 AM Abstract 227 - Neural Correlates of Sentence Repetition in the Logopenic Variant of Primary Progressive Aphasia
Drew Goldberg
07:30 AM - 11:00 AM Abstract 228 - Predictors of Recovery of Chronic Aphasia
Aarushi Suneja, MD
07:30 AM - 11:00 AM Abstract 229 - Syntactic Processing Skills in the Three Variants of PPA
Rajani Sebastian, PhD
07:30 AM - 11:00 AM Abstract 230 - Language networks imaging in Primary Progressive Aphasia in a Latin population
Ismael Calandri, MD
07:30 AM - 11:00 AM Abstract 231 - Impairment in Sentence Comprehension in Patients with the Behavioral Variant of Frontotemporal Degeneration (bvFTD)
Rebecca B. Williams
07:30 AM - 11:00 AM Abstract 232 - 18F-FDG-PET metabolic patterns in the semantic variant of PPA: Functional/clinical correlations. Single-subject 18F-FDG-PET beyond MRI
Daniela Perani, MD
07:30 AM - 11:00 AM Abstract 233 - Sensitivity of Consensus Criteria in the Quantitative Classification of Primary Progressive Aphasia
Meredith Wicklund, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 234 - Bilingualism and language networks in the semantic variant of primary progressive aphasia.
Ismael Calandri, MD
07:30 AM - 11:00 AM Abstract 235 - Correlation between Cortical Thickness Measurements from Magnetic Resonance Imaging and Cognitive Performance on Episodic and Semantic Memory Tests
Ignacio Demey, MD, PhD
07:30 AM - 11:00 AM Abstract 236 - Preservation of Spatial Function: Role in Differential Diagnosis of Behavioral Variant Frontotemporal Dementia
Anneliese Radke
07:30 AM - 11:00 AM Abstract 237 - Validation of the Dynamic Affect Recognition Test (DART): Behavior and Anatomy in Neurodegenerative Disease
Anneliese Radke
07:30 AM - 11:00 AM Abstract 238 - Cognitive Deficits of Large-Vessel and Small-Vessel Vascular Dementia
Ju-Young Na
07:30 AM - 11:00 AM Abstract 239 - White Matter Disease and Cognitive Impairment in FMR1 Premutation Carriers
Christopher M. Filley, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 240 - Age Effects on the Neural Basis of Self-Generation in Verbal Paired Associate Learning
Jerzy P. Szaflarski, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 241 - Accentuated brain responses during semantic object memory retrieval in amnestic mild cognitive impairment as measured by event-related potentials
Hsueh-Sheng Chiang, MD, PhD
07:30 AM - 11:00 AM Abstract 242 - Relationship Between Dementia Severity Ratings And Memory Accuracy Vs. Certainty
Matthew Harris
07:30 AM - 11:00 AM Abstract 243 - Changes of Face Recognition after Medial Temporal Lobe Resection
Masoud Majed, MD
07:30 AM - 11:00 AM Abstract 244 - A Case of Perioperative Stroke caused by Tumour Embolus.
Stella E. Hughes, MD
07:30 AM - 11:00 AM Abstract 245 - Thrombosis of the Vein of Trolard Secondary to Renal Minimal Change Disease: A Case Report and Literature Review
Marcelo Rocha, MD, PhD
07:30 AM - 11:00 AM Abstract 246 - A case of akinetopsia
Wolfgang Grisold, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 248 - A case series of non-bacterial thrombotic endocarditis associated with gynecological malignancies
Alice J. Schabas, MD
07:30 AM - 11:00 AM Abstract 249 - Pituitary Apoplexy Presenting as Anterior Choroidal Artery Territory Infarct: A Case Report
Sasikanth Gorantla, MD
07:30 AM - 11:00 AM Abstract 250 - Lacunar Infarct Presenting Like Axillary Nerve Lesion: A case report
07:30 AM - 11:00 AM Abstract 251 - Case of Neurosyphilis Presenting as MoyaMoya Syndrome
Saima Ali, MD
07:30 AM - 11:00 AM Abstract 252 - Two Cases of Malignant Cerebral Edema Related to Systemic Lupus Erythematous
Lauren Koffman, DO, MS
07:30 AM - 11:00 AM Abstract 253 - Case Report: Multiple Scattered Ischemic and Hemorrhagic Strokes after Transarterial Chemoembolization for Hepatocellular Carcinoma
Alhamza Al-Bayati, MD
07:30 AM - 11:00 AM Abstract 256 - Generalized Dilative Arteriopathy without Myopathy: A New Phenotype of Pompe Disease
07:30 AM - 11:00 AM Abstract 257 - Brain herniation due to mitochondrial encephalomyopathy, lactic acidosis, stroke like events (MELAS) with 3256 mutation responsive to decompressive craniotomy
Chunmei Cui, MD
07:30 AM - 11:00 AM Abstract 259 - Synthetic Cannabis and Acute Ischemic Stroke
Miya Bernson-Leung, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 260 - A novel heterozygous c.164G>C mutation in the exon 2 of the NOTCH3 gene causing Cadasil
Raphael Hourez, MD, PhD
07:30 AM - 11:00 AM Abstract 261 - Amusia: Unique presentation of stroke
Charu Ramchandani, MD
07:30 AM - 11:00 AM Abstract 263 - Right hemispheric acute ischemic stroke secondary to right common carotid artery free floating thrombus due to hypercoagulable state in an otherwise healthy 48-year-old woman.
Karen D. Orjuela, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 264 - Uncomon Cause Stroke: Thalamic Stroke As Initial Presentation Of Dunnigan Familial Partial Lipodystrophy (FPLD)
Fatai Radji, MD
07:30 AM - 11:00 AM Abstract 266 - “Pseudostroke”: Clinically Diagnosed Ischemia Shown to Be Multiple Sclerosis at Autopsy, A Case Report
Gulshan Uppal, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 267 - Delayed Cortical Blindness after Cardiac Arrest
Anibal Lugo, MD
07:30 AM - 11:00 AM Abstract 268 - Case Report - Cerebral Amyloid Angiopathy with Granulomatous Angiitis
Ali Saeed, MD
07:30 AM - 11:00 AM Abstract 269 - Paradoxical Cerebral Embolism from Thrombolysis of a Clotted Arteriovenous Graft
Umang M. Shah, MD
07:30 AM - 11:00 AM Abstract 270 - A Rare Association between Ulcerative Colitis and Bilateral Thalamic Stroke
07:30 AM - 11:00 AM Abstract 271 - Monocular diplopia after left posterior cerebral artery territory infarction
07:30 AM - 11:00 AM Abstract 272 - Rapid High Volume CSF Loss: A New Cause of Coma
Minjee Kim, MD
07:30 AM - 11:00 AM Abstract 274 - Visit-to-visit Systolic Blood Pressure Variability Predicts All-Cause and Cardiovascular Mortality after Lacunar Infarct
Gary K. Lau, MBBS
07:30 AM - 11:00 AM Abstract 275 - Medicare's New Two Midnight Rule for In-patient Status Admission Applied to Transient Ischemic Attack Patients Predicted by Hypertension History and Age
Maria O. Chavez, MD
07:30 AM - 11:00 AM Abstract 276 - High Burden of Brain Microvascular Disease in Difficult-to-Control Hypertension
Maria C. Zurru, MD
07:30 AM - 11:00 AM Abstract 277 - Comparison of classical risk factors, lypids, stress and depression among patients with first ischemic stroke and acute myocardial infarction in a Center from Buenos Aires.
07:30 AM - 11:00 AM Abstract 278 - Analysis of Comorbidities in Ischemic Stroke Patients
Thomas Cochran
07:30 AM - 11:00 AM Abstract 279 - Low Density Lipoprotein Receptor Related Protein-1 and 6 Gene Variants and Ischemic Stroke Risk
Andrea Harriott, MD
07:30 AM - 11:00 AM Abstract 281 - Analysis of the Relation Between Chronic Kidney Disease and Acute Ischemic Stroke.
Patricio Blaya, MD
07:30 AM - 11:00 AM Abstract 282 - The Relationship between Leukocytosis and Time to Neurodeterioration
Amelia K. Boehme, PhD
07:30 AM - 11:00 AM Abstract 283 - Incidence, Seasonality and Comorbidity in Vestibular Neuritis
Ivan Adamec
07:30 AM - 11:00 AM Abstract 284 - Retinal Ganglion Cell Injury Precedes RNFL loss In Acute Optic Neuritis
John R. Guy, MD
07:30 AM - 11:00 AM Abstract 285 - Gordon Holmes 100 years later: Cortical folding predicts retinotopic organization
Noah Benson
07:30 AM - 11:00 AM Abstract 286 - Retinal Structure and Function in Adults with Refractory Complex Partial Seizures (rCPS) Treated with Vigabatrin: Initial Results of the Sabril Vision Study
Robert T. Wechsler, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 287 - Vision-Based Concussion Testing in a Youth Ice Hockey Cohort: Effects of Age and Visual Crowding
Jennifer Morganroth, MD, MBA
07:30 AM - 11:00 AM Abstract 289 - Quantitative Video-oculography to Differentiate Stroke from Vestibular Neuritis in Acute Vertigo?Vestibulo-ocular Reflex Gain Distributions and Optimal Test Thresholds for Diagnosis
Ali Saber Tehrani, MD
07:30 AM - 11:00 AM Abstract 290 - Susac's Syndrome: Five Cases with Predominant Branch Retinal Artery Occlusion
Thomas Seifert, MD
07:30 AM - 11:00 AM Abstract 291 - Correlation of Acute Phase Reactants and Temporal Artery Biopsy (TAB) in Patients with Giant Cell Arteritis (GCA)
Padmaja Sudhakar, MD
07:30 AM - 11:00 AM Abstract 292 - Clinical and electrophysiological photostress recovery times in distinguishing demiyelinating optic neuritis and maculopathy
Fethi Idiman, MD
07:30 AM - 11:00 AM Abstract 293 - A Retrospective study of Chronic Relapsing Inflammatory Optic Neuropathy (CRION)
Padmaja Sudhakar, MD
07:30 AM - 11:00 AM Abstract 294 - Eye movement features in rare hereditary parkinsonian syndromes
07:30 AM - 11:00 AM Abstract 295 - Ocular Motility Disturbances in Orbitofacial Neurofibromatosis Type 1
Thomas M. Bosley, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 296 - Neurosurgical Cases with Cortical Vision Loss followed by Improvement
Bonnie M. Keung, MD
07:30 AM - 11:00 AM Abstract 297 - Optical Coherence Tomography Quadrant Analysis of Retinal Nerve Fiber Layer in Relapsing and Remitting Multiple Sclerosis
John W. Rose, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 298 - Demyelinating Optic Chiasmopathy Due to Mycobacterium Haemophilum in a Patient with AIDS
Alexander Merkler, MD
07:30 AM - 11:00 AM Abstract 299 - Visual evoked potential and magnetic resonance imagine are more effective markers of multiple sclerosis progression than laser polarimetry with variable corneal compensation
07:30 AM - 11:00 AM Abstract 300 - Presence of AQP4 Antibodies Correlates with Negative Outcome of Optic Neuritis
Jana Lizrova
07:30 AM - 11:00 AM Abstract 301 - Evidence of multi-domain mild cognitive impairment in Idiopathic Intracranial Hypertension
Anat Kesler, MD
07:30 AM - 11:00 AM Abstract 302 - ‘Ping-pong' gaze in Hypoglycemic Encephalopathy
Saima Ali, MD
07:30 AM - 11:00 AM Abstract 303 - Do Not Forget Susac Syndrome in Patients with Unexplained Acute Confusion
Michael J. Star, MD
07:30 AM - 11:00 AM Abstract 304 - Clinical utility of cervical vestibular evoked myogenic potential (VEMPc) in Ménière's disease
Guillermo Videla, MD
07:30 AM - 11:00 AM Abstract 305 - An unusual case of Idiopathic Intracranial Hypertension presenting with simultaneous IIIrd, VIth and V11th nerve palsies
Akshat Katyayan, MD
07:30 AM - 11:00 AM Abstract 306 - Restricted Diffusion Imaging In Active Seizure: A Case Report
Adnan Subei, DO, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 307 - Presence of AQP4 Antibodies Correlates with Negative Outcome of Optic Neuritis
Jana Preiningerova, MD
07:30 AM - 11:00 AM Abstract 308 - Diplopia and Esophoria Induced by Medial Thalamic Deep Brain Stimulation
Barbara Changizi, MD
07:30 AM - 11:00 AM Abstract 309 - Decline in perceptual motor speed and cognitive flexibility associated with regional patterns of FDG PET hypometabolism
Alan Lerner, MD
07:30 AM - 11:00 AM Abstract 310 - A fMRI Graph Theory Study of the Effect of Gender and Aging on Topology of Functional Brain Networks
Gianna Carla Riccitelli
07:30 AM - 11:00 AM Abstract 311 - Early Striatal Perfusion Deficits in Autosomal Dominant Alzheimer Disease Detected with Arterial Spin Labeled MRI.
Eric M. McDade, DO
07:30 AM - 11:00 AM Abstract 312 - The effect of age of onset on the brain functional connectivity in Alzheimer's disease: a graph analysis study
Elisa Canu
07:30 AM - 11:00 AM Abstract 315 - Decreased white matter NAA in Alzheimer's Disease
Navid Seraji-Bozorgzad, MD
07:30 AM - 11:00 AM Abstract 316 - Medial Parietal Cortex GABA Measurements in Alzheimer's Disease are Inversely Associated with Functional Response
Novraj Dhanjal, MD
07:30 AM - 11:00 AM Abstract 317 - Dorsolateral Prefrontal Cortex Modulation by Caudate Dopamine During a Working Memory Task in Parkinson Disease
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 318 - Region specific alpha-band resting-state functional connectivity predicts focal cognitive deficits in Alzheimer's disease spectrum
Kamalini G. Ranasinghe, MD, PhD
07:30 AM - 11:00 AM Abstract 320 - Differences in 11C-PIB-PET Imaging Patterns In Patients With Alzheimer's Disease Without Microbleeds And Those With Cerebral Amyloid Angiopathy
Yuichi Hayashi
07:30 AM - 11:00 AM Abstract 321 - Association between Longitudinal Increases in Serum Glucose and Metabolic Decline in Azheimer's Disease-Related Brain Regions
Christine Burns
07:30 AM - 11:00 AM Abstract 322 - Effects of ?-amyloid load on white matter integrity in dementia with Lewy bodies
Zuzana Nedelska, MD, PhD
07:30 AM - 11:00 AM Abstract 325 - [18F]FDG PET Evidence Of Atypical Medial Temporal Lobe Dysfunction In Prodromal Alzheimer's Disease
07:30 AM - 11:00 AM Abstract 326 - PIB-Positive PET in Individuals with Early- but Not Late-Onset Frontotemporal Dementia
07:30 AM - 11:00 AM Abstract 327 - Cavum Septum Pellucidum in Symptomatic Retired Pro-football Players
Raquel Gardner, MD
07:30 AM - 11:00 AM Abstract 328 - Reliable Detection Of Striatal Amyloid With [18F] Flutemetamol: Validation With Postmortem Histopathology
Thomas Beach
07:30 AM - 11:00 AM Abstract 329 - Progressive Hippocampus Atrophy in Persons with Mild Cognitive Impairment: A Longitudinal MRI study
Iryna Lobanova, MD, PhD
07:30 AM - 11:00 AM Abstract 331 - Pathologic validation of the EADC-ADNI Harmonized Hippocampal Protocol
Liana Apostolova, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 332 - Dementia with Lewy bodies: Pathological basis of the cingulate island sign
Jonathan Graff-Radford, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 333 - Progressive Hippocampus Atrophy in Persons with Alzheimer's disease: A Longitudinal MRI study
Iryna Lobanova, MD, PhD
07:30 AM - 11:00 AM Abstract 334 - Genetic Variation within the Oxidative Phosphorylation Pathway in Stroke and Alzheimer's Disease
Alessandro Biffi, MD
07:30 AM - 11:00 AM Abstract 335 - Stereo-electroencephalography versus subdural grids and depth electrode placements: when to use which?
Adetoun Musa, MD
07:30 AM - 11:00 AM Abstract 336 - Critical Intraoperative Neurophysiologic Monitoring (IONM) Changes Associated with Patient Positioning Maneuvers
Leslie H. Lee, MD, FÂ鶹´«Ã½Ó³»­
07:30 AM - 11:00 AM Abstract 337 - Does Intraoperative Neurophysiologic Monitoring (IONM) Cause Delays in Surgical Cases?
Forough Ghavami, DO
07:30 AM - 11:00 AM Abstract 339 - Post Resection Electro-corticography Predicts Seizure Outcome - A Multivariate Logistic Analysis
Sonia N. Krish, MD
07:30 AM - 11:00 AM Abstract 340 - The Predictive Value of Electrocorticography in Patients with Mesial Temporal Lobe Epilepsy Undergoing Selective Amygdalohippocampectomy
Aline Herlopian, MD
07:30 AM - 11:00 AM Abstract 341 - Refractory status epilepticus: a report of two cases to illustrate the significance of GAD antibody
Ayaz M. Khawaja, MD
07:30 AM - 11:00 AM Abstract 342 - NMDA Receptor Encephalitis Presenting as Partial Status Epilepticus. Case Report and Discussion
Simona V. Proteasa, MD
07:30 AM - 11:00 AM Abstract 343 - Is Rasmussen's Encephalitis a NMDA Encephalitis? A Case Report and Review of Literature
Simona V. Proteasa, MD
07:30 AM - 11:00 AM Abstract 344 - Intravenous Immunoglobulin Therapy for Late-Stage Rasmussen's Encephalitis: Long-Term Seizure Freedom
Rahul H. Dave, MD, PhD
Faculty Disclosures
Tracy A. Glauser, MD Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. The institution of Dr. Glauser has received research support from NIH. Dr. Glauser has received intellectual property interests from a discovery or technology relating to health care. Dr. Glauser has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jeremy D. Schmahmann, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Steven T. DeKosky, MD, FÂ鶹´«Ã½Ó³»­ Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Alan J. Thompson, MD, FRCP, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Jose Biller, MD, FACP, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Marinos C. Dalakas, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Raphael Hourez, MD, PhD No disclosure on file
Steven Shook, MD Dr. Shook has nothing to disclose.
Hans-Peter Hartung, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Jouko I. Isojarvi, MD, PhD No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Fabrizio Salvi, MD No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Vijayshree Yadav, MD, FÂ鶹´«Ã½Ó³»­ Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Michael V. Johnston, MD No disclosure on file
Benjamin J. Osborne, MD, FÂ鶹´«Ã½Ó³»­ Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.
Dorothea A. Buck, MD No disclosure on file
Deborah A. Lee, MD, PhD No disclosure on file
P. James B. Dyck, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Michael S. Okun, MD, FÂ鶹´«Ã½Ó³»­ Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
John Hart, MD The institution of Dr. Hart has received research support from Department of Defense.
Kenneth A. Levin, MD No disclosure on file
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
Zbigniew K. Wszolek, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Stefan M. Pulst, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Marc Dinkin, MD Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
David E. Newman-Toker, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Adam B. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison.
Silva Markovic-Plese, MD, FÂ鶹´«Ã½Ó³»­ Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Ana Recober-Montilla, MD Dr. Recober-Montilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Recober-Montilla has received intellectual property interests from a discovery or technology relating to health care.
Michael Levy, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Christopher Ward No disclosure on file
Thomas D. Bird, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bird has nothing to disclose.
Gail H. Marracci, PhD No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Alhamza Al-Bayati, MD Dr. Al-Bayati has nothing to disclose.
Diego Torres-Russotto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Mark E. Landau, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Tal Shany-Ur, PhD No disclosure on file
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
William O. Tatum IV, DO, FÂ鶹´«Ã½Ó³»­ Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a Â鶹´«Ã½Ó³»­ Section Chair of Clinical Neurophysiology with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
John E. Greenlee, MD, FÂ鶹´«Ã½Ó³»­ Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
David S. Goldstein, MD, PhD Dr. Goldstein has received publishing royalties from a publication relating to health care.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FÂ鶹´«Ã½Ó³»­ Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Timothy Lesnick No disclosure on file
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Christopher M. Filley, MD, FÂ鶹´«Ã½Ó³»­ Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Chong S. Lee, MD, FRCPC Dr. Lee has nothing to disclose.
Andrew H. Ahn, MD, PhD Dr. Ahn has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Fred D. Lublin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Kimford J. Meador, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from the NIH.
Fernando Cendes, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
John M. Bertoni, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bertoni has nothing to disclose.
William J. Litchy, MD, FÂ鶹´«Ã½Ó³»­ Dr. Litchy has nothing to disclose.
Bruce L. Miller, MD, FÂ鶹´«Ã½Ó³»­ Dr. Miller has nothing to disclose.
Michael R. Sperling, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Jorge C. Kattah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Edmond Teng, MD, PhD Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Edward M. Manno, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
David H. Salat David H. Salat has or had stock in Niji.David H. Salat has or had stock in Smart Ion. The institution of David H. Salat has received research support from Renew.
Hossein Ansari, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NOEMA Pharmaceutical . Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BIOHAVEN Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioDelivery Sciences International, Inc. . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MedLegal Network. Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Litogation Legal insight ( LITILI). Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FOLAND, WICKENS, ROPER, HOFER & CRAWFORD, P.C.
Laura J. Balcer, MD, MSCE, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Jaime R. Lopez, MD An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
HaeWon Shin, MD The institution of Dr. Shin has received research support from NIH RO1. The institution of Dr. Shin has received research support from NIH U Grant. The institution of Dr. Shin has received research support from UCB. The institution of Dr. Shin has received research support from Biogen. The institution of Dr. Shin has received research support from Neuropace. The institution of Dr. Shin has received research support from Praxis Precision Medicine.
Nizar Souayah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Katya Rascovsky No disclosure on file
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Pierre Clavelou, MD, PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Francisco J. Quintana, PhD Dr. Quintana has nothing to disclose.
Stephen G. Reich, MD, FÂ鶹´«Ã½Ó³»­ Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Daniel Weintraub Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Mark A. Ross, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Murray Grossman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
James W. Wheless, MD, FAAP, FACP, FAES, FCNS, FÂ鶹´«Ã½Ó³»­ Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Lauren Phillips, MD Dr. Phillips has nothing to disclose.
Pooja Khatri, MD, FÂ鶹´«Ã½Ó³»­ Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silvercreek. The institution of Dr. Khatri has received research support from NIH/NINDS. The institution of Dr. Khatri has received research support from AHA. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Cris S. Constantinescu, MD, PhD Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Sarah A. Morrow, MD, MSC, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Murray S. Flaster, MD, PhD No disclosure on file
Naim I. Haddad, MD, FÂ鶹´«Ã½Ó³»­ Dr. Haddad has nothing to disclose.
Marta Radaelli Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Fidias E. Leon-Sarmiento No disclosure on file
William E. Klunk, MD, PhD No disclosure on file
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Oscar L. Lopez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Kailash P. Bhatia, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Bhatia has received publishing royalties from a publication relating to health care.
Eric M. McDade, DO Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Alzheimer's Association. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.
Stephan Zuchner, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Kyle B. Womack, MD The institution of Dr. Womack has received research support from NIH. The institution of Dr. Womack has received research support from Janssen.
Alexandru C. Barboi, MD Dr. Barboi has nothing to disclose.
Christopher M. DeGiorgio, MD, FÂ鶹´«Ã½Ó³»­ Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care.
Luisa Chiapparini, MD No disclosure on file
S H. Subramony, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex. The institution of Dr. Subramony has received research support from Sanofi.
Amy W. Amara, MD PhD The institution of Dr. Amara has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics, Inc. The institution of Dr. Amara has received research support from Michael J Fox Foundation for Parkinson's Research . The institution of Dr. Amara has received research support from Biogen Idec. The institution of Dr. Amara has received research support from NIH.
Ludwig Kappos, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kappos has nothing to disclose.
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Glenn E. Smith, MD, PhD No disclosure on file
Donald A. Barone, DO Dr. Barone has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vanda. Dr. Barone has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono.
Jeremy D. Slater, MD, FÂ鶹´«Ã½Ó³»­ Dr. Slater has received personal compensation for serving as an employee of Stratus. Dr. Slater has stock in Zeto LLC.
Marcelo E. Bigal, MD, PhD No disclosure on file
Halina Bartosik-Psujek No disclosure on file
Moses Rodriguez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Victoria Leavitt, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Tetsuo Ashizawa, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Sachin Kedar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kedar has nothing to disclose.
Drini Dobi, MD, PhD No disclosure on file
Robert N. Schwendimann, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Subasini Dash, MD No disclosure on file
Sara A. Simpson, MD No disclosure on file
Mehmet Senol No disclosure on file
Pariwat Thaisetthawatkul, MD, FÂ鶹´«Ã½Ó³»­ Dr. Thaisetthawatkul has nothing to disclose.
Mari Heininen-Brown, BA No disclosure on file
Samuel Yip, MD, PhD Dr. Yip has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mitra Assadi Khansare, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Max J. Hilz, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Daniela Perani, MD No disclosure on file
Ali Saber Tehrani, MD Dr. Saber Tehrani has nothing to disclose.
Hamid Ebadi, MD No disclosure on file
Clifton L. Gooch, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Daniel J. Bonthius, MD No disclosure on file
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Panayiotis N. Varelas, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Varelas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Giammarco, Mullins & Horton P.C. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Un of Michigan. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with Â鶹´«Ã½Ó³»­. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with Â鶹´«Ã½Ó³»­. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Venu Parachuri, MD No disclosure on file
Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
David B. Watson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Watson has nothing to disclose.
Rohit Bakshi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
William J. Byrnes, MD No disclosure on file
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Duarte G. Machado, MD, FÂ鶹´«Ã½Ó³»­ Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Tamer Abdelhak, MD Dr. Abdelhak has nothing to disclose.
Anthony E. Lang, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Antonia Ceccarelli, MD, PhD No disclosure on file
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Richard A. Hughes, MD Dr. Hughes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Nerses Sanossian, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Craig Carroll, DO No disclosure on file
Kenneth M. Heilman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Heilman has received publishing royalties from a publication relating to health care.
Michael D. Geschwind, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Claudia F. Lucchinetti, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Joseph E. Safdieh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Timothy M. Miller, MD, PhD Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Bio. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. The institution of Dr. Miller has received research support from Ionis Pharmaceuticals . Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Jerzy P. Szaflarski, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Michael Oshinsky, PhD No disclosure on file
Emilia M. Gatto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Miya Bernson-Leung, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioMarin. Dr. Bernson-Leung has stock in Abbott Labs. Dr. Bernson-Leung has stock in Abbvie Inc.
Olga Waln, MD Dr. Waln has nothing to disclose.
Omar A. Khan, MD, PhD No disclosure on file
Kenneth D. Laxer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Laxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Lfe Sciences. Dr. Laxer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Guillermo Videla, MD No disclosure on file
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Robert C. Sergott, MD Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Martin Goldstein, MD No disclosure on file
Steven Jacobson Steven Jacobson has nothing to disclose.
Lixin Zhang-Auberson, MD, PhD No disclosure on file
Ingemar S. Merkies, MD No disclosure on file
Jeremy C. Hobart, MD Dr. Hobart has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Hobart has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Scott Przybelski Scott Przybelski has nothing to disclose.
Stephen Sidney, MD, MPH Dr. Sidney has nothing to disclose.
James C. Watson, MD No disclosure on file
Jacqueline French, MD, FÂ鶹´«Ã½Ó³»­ Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Sherry Hsiang-Yi Chou, MD Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Sulev Haldre, PhD No disclosure on file
Jeffery Gunter The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Jane Boggs, MD The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Tiffany W. Chow, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.
Christopher H. Hawkes, MD, Bsc, FRCP, FÂ鶹´«Ã½Ó³»­ Dr. Hawkes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jeffrey L. Bennett, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Maria C. Zurru, MD No disclosure on file
Thomas M. Bosley, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Masatoyo Nishizawa, MD No disclosure on file
Andrea N. Leep Hunderfund, MD The institution of Dr. Leep Hunderfund has received research support from American Medical Association. The institution of Dr. Leep Hunderfund has received research support from Kern National Network for Caring and Character in Medicine. Dr. Leep Hunderfund has received intellectual property interests from a discovery or technology relating to health care.
Wolfgang Grisold, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Keith A. Josephs, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Josephs has nothing to disclose.
Julian Benito-Leon No disclosure on file
Mohammad S. Alhalabi, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nascimento has nothing to disclose.
Joseph Herbert, MD No disclosure on file
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Xavier Montalban, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Helio Afonso G. Teive, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Teive has nothing to disclose.
Ann Marie Collier, MD, FÂ鶹´«Ã½Ó³»­ Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW BIosciences. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LivaNova. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK lifescience.
Eric R. Eggenberger, DO, FÂ鶹´«Ã½Ó³»­ Dr. Eggenberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Welch-Allyn. Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT). Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Steven M. Greenberg, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Scott E. Kasner, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from WL Gore. The institution of Dr. Kasner has received research support from DiaMedica. The institution of Dr. Kasner has received research support from Bayer.
Karen C. Johnston, MD, MSC Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University of Pittsburg. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mayo Clinic. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University of California Irvine. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Johnston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Johnston has received research support from NIH.
Antonio Toscano, MD Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Nancy Monson Nancy Monson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Nancy Monson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenrAb, Inc.. Nancy Monson has stock in GenrAb, Inc.. The institution of Nancy Monson has received research support from NIH. Nancy Monson has received intellectual property interests from a discovery or technology relating to health care.
Haatem M. Reda, MD Dr. Reda has nothing to disclose.
Aline Herlopian, MD Dr. Herlopian has nothing to disclose.
Mario Habek, MD Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Vincenzo Brescia Morra, MD Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Michelle Fabian, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fabian has nothing to disclose.
Vissia Viglietta, MD No disclosure on file
Egemen Idiman, MD No disclosure on file
Marina Boccardi, PhD No disclosure on file
Geoffrey K. Aguirre, MD, PhD Dr. Aguirre has received stock or an ownership interest from Nia therapeutics. The institution of Dr. Aguirre has received research support from Lion's Foundation. The institution of Dr. Aguirre has received research support from National Institutes of Health. The institution of Dr. Aguirre has received research support from Johnson and Johnson. The institution of Dr. Aguirre has received research support from Department of Defense.
Keith Vossel, MD No disclosure on file
Charuta N. Joshi, MD No disclosure on file
Nassim Zecavati, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zecavati has nothing to disclose.
Soundarya Gowda, MD Dr. Gowda has nothing to disclose.
Marlis Gonzalez-Fernandez, MD, PhD No disclosure on file
Peter N. Riskind, MD, PhD No disclosure on file
Stephen Krieger, MD, FÂ鶹´«Ã½Ó³»­ Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Brent P. Goodman, MD Dr. Goodman has nothing to disclose.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Jonathan H. McKinnon, MD No disclosure on file
Carolina Ionete, MD Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Goran Rakocevic, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rakocevic has nothing to disclose.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Jaishri Blakeley, MD, FÂ鶹´«Ã½Ó³»­ Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
R. John Leigh, MD No disclosure on file
Ansgar Furst, PhD MS No disclosure on file
Alex Rovira Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Kristin Schwab No disclosure on file
Innocenzo Rainero, MD, PhD No disclosure on file
Edip M. Gurol, MD The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Annachiara Cagnin No disclosure on file
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Bradley F. Boeve, MD, FÂ鶹´«Ã½Ó³»­ Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Anna D. Hohler, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hohler has nothing to disclose.
Elliot M. Frohman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
David S. Zee, MD Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for florida legal. Dr. Zee has received publishing royalties from a publication relating to health care. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lectuer with u of pittsburg physical therapy. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lecturer with johms hopkins CME.
Claire Riley, MD, FÂ鶹´«Ã½Ó³»­ Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Lisa Hobson-Webb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Hobson-Webb has received research support from Abcuro. The institution of Dr. Hobson-Webb has received research support from Avidity. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­al Talk - not speaker bureau with Takeda. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­al Talk - not speaker bureau with CSL Behring.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Brian G. Weinshenker, MD, FÂ鶹´«Ã½Ó³»­ Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
John A. Detre, MD Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Agnes Fromont No disclosure on file
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Rui Sousa No disclosure on file
Sven O. Jarius, MD Dr. Jarius has nothing to disclose.
Maria V. Alvarez, MD No disclosure on file
Meredith Wicklund, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Leonard S. Li, MD, MBBS No disclosure on file
Joanna E. O'Leary, MD No disclosure on file
Ahmet Onur Keskin, MD No disclosure on file
Samaneh Zandifar No disclosure on file
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Massimo Filippi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Geoffrey A. Kerchner, MD, PhD Dr. Kerchner has received personal compensation for serving as an employee of F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has stock in F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has received publishing royalties from a publication relating to health care.
Magdalena Krbot Skoric Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Mohit Neema, MD No disclosure on file
Ruchir Shah, MD Dr. Shah has nothing to disclose.
Neill R. Graff-Radford, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Joseph J. Higgins, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Pierre Fayad, MD, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Mushtaq H. Qureshi, MD No disclosure on file
Michael Gurevich No disclosure on file
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Gen Sobue, MD Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited..
John G. Whitesides John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB.
Ricardo F. Allegri, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Allegri has nothing to disclose.
Omar Butt, MD No disclosure on file
Israt Jahan, MD No disclosure on file
Tuan H. Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VOR. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR. The institution of Dr. Vu has received research support from NMD Pharma. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with AcademicCME. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with CMEO. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with PER. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with MedLive.
Mona Bahouth, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bahouth has nothing to disclose.
Alejandra Amengual No disclosure on file
Anmar Razak, MD Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Chutima Saipetch, MD No disclosure on file
Elizabeth Sweeney No disclosure on file
Kristina J. Lopez, MD Dr. Lopez has nothing to disclose.
Panayiotis Mitsias, MD The institution of Dr. Mitsias has received research support from European Union.
Zianka Fallil, MD No disclosure on file
Julia Koehn, MD No disclosure on file
Shannon N. Overs, MD No disclosure on file
Richard M. Trosch, MD, FÂ鶹´«Ã½Ó³»­ Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Katherine L. Possin, PhD Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Erez Hanael No disclosure on file
Halit Yasar No disclosure on file
Takashi Inuzuka, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Jonathan M. Beary, DO, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Mary Sano, PhD Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Avenir. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for BioXcel. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for CogRx. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for F. Hoffman LaRoche. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Minerva Neuroscience. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoNordisk. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Pfizer. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for vTv Therapeutics. Dr. Sano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's Association. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Psychogeriatric Association.
Elia Haddad, MD No disclosure on file
Griselda N. Russo, MD, PhD No disclosure on file
Maria J. Bruzzone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bruzzone has nothing to disclose.
Meredith N. Braskie No disclosure on file
Vibhav K. Bansal, MD, JD No disclosure on file
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
Alexander J. Beagle No disclosure on file
Lisa M. Caylor, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Lenore J. Launer, PhD No disclosure on file
Scott Kolodny, MD No disclosure on file
Christopher M. Goshgarian, MD Dr. Goshgarian has nothing to disclose.
Michael T. Flink, DO, PhD No disclosure on file
Christopher D. Anderson, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Antonio G. Gallo, MD No disclosure on file
Muhtesem Gedizlioglu, MD No disclosure on file
Benjamin M. Greenberg, MD, FÂ鶹´«Ã½Ó³»­ Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Myla D. Goldman, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Tania Reyna, MD, FÂ鶹´«Ã½Ó³»­ Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics .
Ge Xiong, MD The institution of Dr. Xiong has received research support from Argenx.
L J. Greenfield, Jr., MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Greenfield has received publishing royalties from a publication relating to health care.
Barbara Changizi, MD Dr. Changizi has nothing to disclose.
A J. Stoessl, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Flavia Mattioli, MD Dr. Mattioli has nothing to disclose.
Roberta Lanzillo Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care.
Luiza G. Piovesana, MD No disclosure on file
Koon Ho Chan, MD, MBBS No disclosure on file
Raymond T. Cheung, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Catarina Quinzii Hirano, MD No disclosure on file
Aleksei Rakitin, MD No disclosure on file
Michael Cartwright, MD Dr. Cartwright has received publishing royalties from a publication relating to health care.
Giovanni B. Frisoni, MD No disclosure on file
Anat Kesler, MD No disclosure on file
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Sat Dev Batish, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Edward Kim, MD Dr. Kim has nothing to disclose.
Jehuda P. Sepkuty, MD No disclosure on file
Manikum Moodley, MD, FÂ鶹´«Ã½Ó³»­ Dr. Moodley has nothing to disclose.
Martina Absinta, MD Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. The institution of Dr. Absinta has received research support from International MS Alliance. The institution of Dr. Absinta has received research support from FRRB Early Career Award. The institution of Dr. Absinta has received research support from Cariplo Foundation.
Wenzhuan He, MD Dr. He has nothing to disclose.
Marcus Ng, MD The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Christina M. Nguyen, MD No disclosure on file
QIANG DONG, PhD No disclosure on file
Christine Burns No disclosure on file
Lilyana M. Amezcua, MD, FÂ鶹´«Ã½Ó³»­ Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
Varun Sethi, MD, PhD No disclosure on file
Kartik Raghupathi No disclosure on file
Viet Nguyen, MD Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Veronica Gorden, BA No disclosure on file
Leendert H. Visser, MD No disclosure on file
Christina Azevedo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Eric M. Reiman, MD Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Dhimant Dani, MD Dr. Dani has nothing to disclose.
Anna Sorokin, MD No disclosure on file
Leslie H. Lee, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lee has nothing to disclose.
Anat Achiron, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Achiron has nothing to disclose.
Gerhard Winkler, MD No disclosure on file
John Powers No disclosure on file
John R. Guy, MD No disclosure on file
Daniel J. Licht, MD No disclosure on file
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Edwin B. George, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Sungho K. Cho, MD Dr. Cho has nothing to disclose.
Dieter Haering Dieter Haering has received personal compensation for serving as an employee of Novartis.
Carole S. Scherling, PhD No disclosure on file
Cesar C. Santos, MD No disclosure on file
Eva Costa Arpin, MD No disclosure on file
Mihir Parikh No disclosure on file
Dennis N. Bourdette, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Heidi A. Bender, PhD No disclosure on file
Adetoun Musa, MD No disclosure on file
Maria Cristina Arci Santos No disclosure on file
John Cole, MD Dr. Cole has nothing to disclose.
Oezguer Yaldizli, MD Dr. Yaldizli has nothing to disclose.
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Ellen M. Mowry, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Brad A. Racette, MD, FÂ鶹´«Ã½Ó³»­ Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Joyce A. Cramer No disclosure on file
Josep O. Dalmau, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Harry Vinters No disclosure on file
Keith A. Johnson, MD Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervGen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. The institution of Dr. Johnson has received research support from National Institute on Aging. The institution of an immediate family member of Dr. Johnson has received research support from Alzheimer's Association. The institution of an immediate family member of Dr. Johnson has received research support from Eli Lilly and Co. The institution of Dr. Johnson has received research support from Eisai. The institution of an immediate family member of Dr. Johnson has received research support from Eisai.
Nathan P. Staff, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Elysa Marco, MD No disclosure on file
Douglas L. Arnold, MD, FÂ鶹´«Ã½Ó³»­ Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Giovanni Savettieri, MD No disclosure on file
Jane B. Allendorfer, PhD The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
David E. Blum, MD Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Franz Fazekas, MD No disclosure on file
Catherine Cho, MD Dr. Cho has nothing to disclose.
Ivan Adamec Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jadran Galenski laboratorij. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Phoenix farmacija.
Catherine Hosley, MD No disclosure on file
Nicolas Collongues, MD Nicolas Collongues, MD has nothing to disclose.
Marc F. Bataillard, MD No disclosure on file
Federica Esposito Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Carla E. Santiago-Martinez Ms. Santiago-Martinez has nothing to disclose.
Luka Vlahovic, MD Dr. Vlahovic has nothing to disclose.
Zubeda B. Sheikh, MD Dr. Sheikh has nothing to disclose.
Aisling Ryan, PhD, MB, FRCPI Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Donna C. Graves, MD, FÂ鶹´«Ã½Ó³»­ Dr. Graves has nothing to disclose.
Veronica A. Bruno, MD Dr. Bruno has nothing to disclose.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
John M. Ringman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Steven Galetta, MD, FÂ鶹´«Ã½Ó³»­ Dr. Galetta has nothing to disclose.
Richard A. Rudick, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Michael J. Schneck, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Anthony Polazzo No disclosure on file
Nizar Chahin, MD Dr. Chahin has nothing to disclose.
Larus S. Gudmundsson, PhD No disclosure on file
Rebecca Spain, MD, MSPH, FÂ鶹´«Ã½Ó³»­ Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Diego Cadavid, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Marcela Fiol Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. The institution of Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Jonathan K. Smith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for OBT Law. Dr. Smith has a non-compensated relationship as a Committee Member, Clinical Neurophysiology CMOC Pilot, with ABPN that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Umang M. Shah, MD No disclosure on file
Olga Ciccarelli, MD, PhD, FRCP Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Alberto R. Martinez, MD No disclosure on file
Mauricio F. Farez, MD Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
David H. Miller, MD, MBChB, FRCP No disclosure on file
Jan Krasensky, MD No disclosure on file
Peter S. Chin, MD No disclosure on file
Stephen L. Yates, PhD Dr. Yates has received personal compensation for serving as an employee of UCB Biosciences, Inc.. Dr. Yates has stock in UCB Biosciences, Inc..
Zhi-Jian Chen, MD Dr. Chen has nothing to disclose.
Brigitte Capron, MD No disclosure on file
Hizir Ulvi, MD No disclosure on file
Michael J. Star, MD Dr. Star has nothing to disclose.
Zhenyuan Wang, PhD Dr. Wang has nothing to disclose.
Manuela Vaneckova Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Seby John, MD Dr. John has nothing to disclose.
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Hans D. Katzberg, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Khaled Asi, MD No disclosure on file
Fen Bao Fen Bao has nothing to disclose.
Manuela Lema Bouzas No disclosure on file
Sebastian F. Von Rosenstiel, MD, PhD Dr. Von Rosenstiel has received personal compensation for serving as an employee of Takeda. Dr. Von Rosenstiel has stock in Takeda.
Paula C. Azevedo, MD Dr. Azevedo has nothing to disclose.
Dana Horakova Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Kimbra L. Kenney, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kenney has nothing to disclose.
Samuel E. Gandy, MD, PhD No disclosure on file
Mohammed A. Hussain, MD No disclosure on file
Nicole M. Warner, ARNP No disclosure on file
Ali Saeed, MD No disclosure on file
Tania F. Tayah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Tayah has nothing to disclose.
Gennaro Bussone No disclosure on file
Andrew Cole, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Cole has received publishing royalties from a publication relating to health care.
Philip A. Teal, MD Dr. Teal has nothing to disclose.
Thomas P. Naidich, MD No disclosure on file
Angela B. Deutschlander, MD No disclosure on file
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Ayesha Sherzai, MD No disclosure on file
Zachary Miller, MD Dr. Miller has nothing to disclose.
Machteld E. Hillen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hillen has received research support from Genentech.
George R. Wilmot, MD, PhD Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
Sheryl Martin-Schild, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Stephen J. Marks, MD No disclosure on file
Peter J. Dyck, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dyck has nothing to disclose.
Ehud Lavi, MD No disclosure on file
Maheep S. Virdi, MD No disclosure on file
Alfredo Damasceno, MD No disclosure on file
Louis C. Tan, MRCP No disclosure on file
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Alexander Merkler, MD Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Jera Kruja, MD Dr. Kruja has nothing to disclose.
Rasha Abdel-Fahim No disclosure on file
Jonathan Graff-Radford, MD, FÂ鶹´«Ã½Ó³»­ Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Felix Schmidt No disclosure on file
Ahmad Riad Ramadan, MD Dr. Ramadan has received publishing royalties from a publication relating to health care. Dr. Ramadan has received publishing royalties from a publication relating to health care.
Massimiliano Copetti No disclosure on file
Ioannis Karakis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Balaji Krishnaiah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACP. Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual. Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Chunmei Cui, MD No disclosure on file
Ritika Mahajan, MD No disclosure on file
Dominique Monlezun, Jr No disclosure on file
Shannon Sparrow No disclosure on file
Orlando G. Barsottini, MD, PhD Dr. Barsottini has nothing to disclose.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Mohammed Rehman, DO Dr. Rehman has nothing to disclose.
Kiran P. Maski, MD An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Benito P. Damasceno, MD, PhD No disclosure on file
Gulshan Uppal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Uppal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Uppal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Rajat Lahoria, MD No disclosure on file
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Guangbin Xia, MD, PhD No disclosure on file
Ari Breiner, MD Dr. Breiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Breiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Breiner has received research support from Deparment of Medicine, University of Ottawa.
Jorge Campos, MD No disclosure on file
Arpita Chattopadhyay No disclosure on file
Hakan Akgun No disclosure on file
Gilles Defer, MD Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Salman Azhar, MD Dr. Azhar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic.
Rejean M. Guerriero, MD Dr. Guerriero has nothing to disclose.
Delphin Sallowm, MD Dr. Sallowm has nothing to disclose.
Adam Friedant, DO Dr. Friedant has nothing to disclose.
Hyunjin Kim, MD Dr. Kim has nothing to disclose.
Jose Luiz Pedroso, MD Dr. Pedroso has nothing to disclose.
Joseph Menzin, PhD No disclosure on file
Tatiana Koudriavtseva, MD No disclosure on file
Greg M. Thaera, MD No disclosure on file
Masayoshi Tada, MD, PhD No disclosure on file
Cameron Davis, MS No disclosure on file
Kavita M. Grover, MD, FÂ鶹´«Ã½Ó³»­ Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Ikjae Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Thomas Cochran No disclosure on file
Anna L. Isenberg, PhD No disclosure on file
Daniel Kaufer, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Heidi B. Schwarz, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.
Richard S. Burns, MD No disclosure on file
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Jesus Lovera, MD Dr. Lovera has nothing to disclose.
Nobuaki Yoshikura, MD, PhD Dr. Yoshikura has nothing to disclose.
Alessandro Biffi, MD Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Rachel P. Guimaraes, PT Ms. Guimaraes has nothing to disclose.
Supurna Ghosh, PhD Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Forough Ghavami, DO No disclosure on file
Ann Scher, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Jeffery P. Hogg, MD No disclosure on file
Timothy K. Vartanian, MD, PhD Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Vartanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Vartanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tisch MS Center. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Amy T. Waldman, MD Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Zhixiao Wang, PhD No disclosure on file
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Galeno Rojas, MD No disclosure on file
Alaleh Raji, MD No disclosure on file
Neeta Garg, MD Dr. Garg has nothing to disclose.
Charles Cho No disclosure on file
Natalya Shneyder, MD Dr. Shneyder has nothing to disclose.
Scheherazade Le, MD Dr. Le has nothing to disclose.
Douglas C. Smith, MD, PhD No disclosure on file
Danilo Bernardo, MD No disclosure on file
Ashesh Mehta No disclosure on file
Lisa Burkholder No disclosure on file
Syed I. Hussain, MD Dr. Hussain has nothing to disclose.
Lauren Koffman, DO, MS Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm. Dr. Koffman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Walters Kluwer.
Abdulrahman Alwaki, MD Dr. Alwaki has nothing to disclose.
Shana S. Krstevska, MD No disclosure on file
Paul M. George, MD, PhD, MSE, FÂ鶹´«Ã½Ó³»­ Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $10,000-$49,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Himali R. Jayakody, MD Dr. Jayakody has nothing to disclose.
Saima Ali, MD No disclosure on file
Sreenivas Avula, MD Dr. Avula has nothing to disclose.
Rick Gill, MD Dr. Gill has nothing to disclose.
Fiona E. Costello, MD Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Henry L. Paulson, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Janet Berkley No disclosure on file
Trevor J. Kilpatrick, MBBS, PhD Dr. Kilpatrick has received stock or an ownership interest from Mx3 diagnostics. The institution of Dr. Kilpatrick has received research support from NHMRC. The institution of Dr. Kilpatrick has received research support from NMSS. The institution of Dr. Kilpatrick has received research support from MSRA. Dr. Kilpatrick has received intellectual property interests from a discovery or technology relating to health care. Dr. Kilpatrick has received publishing royalties from a publication relating to health care.
Cormac A. O'Donovan, MD Dr. O'Donovan has nothing to disclose.
Pedro S. Oliveira, MD No disclosure on file
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Chandan B. Mehta, MD Dr. Mehta has nothing to disclose.
Marta San Luciano, MD, FÂ鶹´«Ã½Ó³»­ Dr. San Luciano has received research support from NIH (NINDS). Dr. San Luciano has received research support from Raynor Cerebellum Project.
Jodie Burton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Burton has a non-compensated relationship as a Â鶹´«Ã½Ó³»­al Chair with EMD Serono that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Clinton B. Wright, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Wright has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Abali Milne Kalil. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Molly K. King, MD No disclosure on file
David K. Urion, MD, FÂ鶹´«Ã½Ó³»­ Dr. Urion has nothing to disclose.
Annapoorna Bhat, MD Dr. Bhat has nothing to disclose.
Fernando Dangond, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Fernando F. Figueira, MD No disclosure on file
Ellen Carl, MS No disclosure on file
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Prityi Rani, MD No disclosure on file
Michael Hecker, PhD No disclosure on file
Ramy El Khoury, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Vikram Shakkottai, MD, PhD The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Brij M. Ahluwalia-Singh, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Justin Murphy, MD Dr. Murphy has nothing to disclose.
Susanna Usai No disclosure on file
Adam J. Simon, PhD No disclosure on file
Xuemei Huang, MD, PhD Dr. Huang has received personal compensation for serving as an employee of NIH. Dr. Huang has received personal compensation for serving as an employee of DoD. The institution of Dr. Huang has received research support from NIH.
Umer Akbar, MD Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Osamu Onodera, MD Dr. Onodera has nothing to disclose.
Ghaniah Hassan-Smith No disclosure on file
Enrique A. Serrano, MD No disclosure on file
Kalidoss Ramadoss No disclosure on file
Rahul H. Dave, MD, PhD No disclosure on file
Salvatore DiMauro, MD No disclosure on file
Joseph R. Berger, MD, FÂ鶹´«Ã½Ó³»­ Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Nathalie Guy Renouil, MD No disclosure on file
Michael J. Doherty, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Yuichi Hayashi Yuichi Hayashi has nothing to disclose.
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Xiaojun You, PhD No disclosure on file
Norman Latov, MD, PhD Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Milena Pavlova, MD Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pear Therapeutics. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Oakstone. The institution of Dr. Pavlova has received research support from Jazz. The institution of Dr. Pavlova has received research support from Vanda. The institution of Dr. Pavlova has received research support from Biomobie. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving as a Didactic article with Neurodiem.
Laila Gharzai No disclosure on file
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Daniel Friedman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. The institution of Dr. Friedman has received research support from Rapport Therapeutics. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with Â鶹´«Ã½Ó³»­. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America.
Anibal Lugo, MD No disclosure on file
Rachel Godfred No disclosure on file
Leighton Hinkley, PhD Dr. Hinkley has nothing to disclose.
Gaetan Garraux, MD No disclosure on file
Govind Bhagavatheeshwaran Mr. Bhagavatheeshwaran has received research support from National Institutes of Health.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Robert T. Wechsler, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Haitham Dababneh, MD No disclosure on file
Geert G. Brekelmans, MD No disclosure on file
Scott R. Haines, MD No disclosure on file
Anya Turetsky, MD No disclosure on file
Ignacio Demey, MD, PhD Ignacio Demey, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Laboratorio Bagó.
Raya Massoud, MD No disclosure on file
Dong-Hui Chen, MD, PhD No disclosure on file
Michelle Cameron, MD Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Bennett L. Lavenstein, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Navid Seraji-Bozorgzad, MD No disclosure on file
Matthew Imperioli, MD Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx Pharmaceuticals . Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law offices of Scott Doody.
Jennifer K. Lynch, MD No disclosure on file
Mohammad H. El-Ghanem, MD Dr. El-Ghanem has nothing to disclose.
Ismael Calandri, MD Dr. Calandri has nothing to disclose.
Idanis Berrios Morales, MD Dr. Berrios Morales has nothing to disclose.
Charles H. Adler, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Osama O. Zaidat, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zaidat has nothing to disclose.
Ayaz M. Khawaja, MD Dr. Khawaja has nothing to disclose.
Sha Mi, PhD No disclosure on file
Zoltan Mari, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ACADIA. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parkinson Study Group. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ACADIA. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Moore and Moore PLLC. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Francis Law Firm PLLC. Dr. Mari has stock in NeuroReserve. Dr. Mari has stock in Sensory Cloud. The institution of Dr. Mari has received research support from Cerevel. The institution of Dr. Mari has received research support from AbbVie. The institution of Dr. Mari has received research support from NIH. The institution of Dr. Mari has received research support from Parkinson's Foundation. The institution of Dr. Mari has received research support from Michael J Fox Foundation. The institution of Dr. Mari has received research support from LBDA. The institution of Dr. Mari has received research support from Eli Lilly.
J. Americo M. Fernandes, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Doris J. Doudet, PhD No disclosure on file
Ryan D. Walsh, MD No disclosure on file
Mark B. Bromberg, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $10,000-$49,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Pedro Braga-Neto, MD, PhD Dr. Braga-Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Braga-Neto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Andrew A. Wolff, MD No disclosure on file
Hsueh-Sheng Chiang, MD, PhD The institution of Dr. Chiang has received research support from NIH/NIDCD. The institution of Dr. Chiang has received research support from Texas Alzheimer's Research and Care Consortium.
Barbara Teter, PhD MPH No disclosure on file
Brooke Hayward, SM, MBA Brooke Hayward, SM, MBA has received personal compensation for serving as an employee of EMD Serono, Inc., Rockland, MA USA, an affiliate of Merck KGaA, Darmstadt, Germany.
Rohini Bhole, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Bhole has nothing to disclose.
Ramandeep Sahni, MD Dr. Sahni has nothing to disclose.
Omotola A. Hope, MD Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Gustavo Figueira, MD No disclosure on file
Christopher Gomez, MD, PhD Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Amiram Katz, MD No disclosure on file
Jeffrey Waugh, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from Â鶹´«Ã½Ó³»­.
Sheng-Han Kuo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kuo has nothing to disclose.
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
David S. Tabby, DO, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Niraj A. Arora, MD Dr. Arora has nothing to disclose.
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Elijah Mak No disclosure on file
Sandeep Vaishnavi, MD, PhD No disclosure on file
Lutz Harms No disclosure on file
Steve Chung, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Karla P. Figueroa Ms. Figueroa has nothing to disclose.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Mira Kapisyzi, DO No disclosure on file
Gregory A. Elder, MD No disclosure on file
Giridhar P. Kalamangalam, MD, PhD Dr. Kalamangalam has nothing to disclose.
Jorge Martin Gavidia Chucan, MD No disclosure on file
Jana Lizrova No disclosure on file
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Sharanpal Mann, MD No disclosure on file
Novraj Dhanjal, MD No disclosure on file
Jonathan Howard, MD Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Kristina M. Fanning, PhD The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Shamaehah Javed, MD No disclosure on file
Sara A. Mayer, MD No disclosure on file
Stefano F. Cappa, MD Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier. The institution of Dr. Cappa has received research support from Italian Minsitry of Health.
Jana Preiningerova, MD No disclosure on file
Nikolaos Evangelou, PhD Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Evangelou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UK crown prosecution service. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis .
Nagaendran Kandiah, MD No disclosure on file
Cynthia I. Guede, NP No disclosure on file
Akshat Katyayan, MD No disclosure on file
Alison May, MD No disclosure on file
Georgia D. Montouris, MD No disclosure on file
Shifang Liu No disclosure on file
Karthikeyan M. Arcot, MD No disclosure on file
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Guillaume Lamotte, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lamotte has nothing to disclose.
Pezhman Roohani, MD No disclosure on file
Melissa Murray, PhD Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
Alexander George No disclosure on file
Gabriela Cohen, MD No disclosure on file
Gilmar F. Prado, MD No disclosure on file
Jens Watzlawik No disclosure on file
Stacey Clardy, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/Â鶹´«Ã½Ó³»­ Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ Summer Meeting CoDirector Travel and Lodging with Â鶹´«Ã½Ó³»­. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Andrea Falini No disclosure on file
Joel Salinas, MD, MBA, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Jeremy Tanner, MD An immediate family member of Dr. Tanner has received personal compensation for serving as an employee of Channeling Hope Foundation. The institution of Dr. Tanner has received research support from NIA, NINDS. Dr. Tanner has a non-compensated relationship as a Chief Scientific Officer with Channeling Hope Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Steven K. Feske, MD Dr. Feske has received publishing royalties from a publication relating to health care.
James F. Meschia, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
David F. Tang-Wai, MD, FRCPC Dr. Tang-Wai has nothing to disclose.
Charles M. Lourenco, MD, PhD No disclosure on file
Benn E. Smith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Radha Mahadevan, MD No disclosure on file
Deepal P. Shah-Zamora, MD Dr. Shah-Zamora has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Winthrop Industrie. The institution of Dr. Shah-Zamora has received research support from CereGate Inc. The institution of Dr. Shah-Zamora has received research support from Amneal. The institution of Dr. Shah-Zamora has received research support from AbbVie .
Drew Goldberg No disclosure on file
Sean J. Pittock, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Kevin N. Sheth, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Seref Demirkaya, PhD No disclosure on file
Nitish Harid No disclosure on file
Glenn A. Phillips, PhD Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
Raymond Y. Lo, MD Dr. Lo has nothing to disclose.
Serdar Tasdemir, MD No disclosure on file
Silvana Riggio, MD No disclosure on file
Fatai Radji, MD Dr. Radji has nothing to disclose.
James T. Becker, PhD No disclosure on file
Thomas W. Smith, MD No disclosure on file
Won-Joo Kim, MD No disclosure on file
Dhairyawan Pokalkar, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ronald G. Haller, MD No disclosure on file
Felicia B. Axelrod, MD No disclosure on file
Sateesh K. Kamera, MD, DM No disclosure on file
James Miller No disclosure on file
Aleksandar Videnovic, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Videnovic has nothing to disclose.
Michio Hirano, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Â鶹´«Ã½Ó³»­. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Richard L. Doty, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Doty has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sensonics International. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for State of Kansas. Dr. Doty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Johnson & Johnson. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for McMahan Law Firm. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Offices of Walkup et al.. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ostroff Injury Law PC. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sacchett & Baldino. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Nebenzahl Law Group. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ohio National Life Insurance Co. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Tatum and Atkinson LLC. Dr. Doty has stock in Sensonics International. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care.
Reyna Duron, MD No disclosure on file
Michael Douglas, MD No disclosure on file
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Gil D. Rabinovici, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with Â鶹´«Ã½Ó³»­. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Bonnie M. Keung, MD No disclosure on file
Joohi Jimenez Shahed, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Â鶹´«Ã½Ó³»­. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Roman Herzig, MD, PhD Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Roman Herzig, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Care Comm.
Abhijeet R. Joshi No disclosure on file
Marijean Buhse Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Katherine A. Riester, MPH No disclosure on file
Radu Tanasescu, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Zahinoor Ismail, MD No disclosure on file
Daniel Vela-Duarte, MD Dr. Vela-Duarte has nothing to disclose.
Myassar Zarif Myassar Zarif has nothing to disclose.
Qian Ma, MD, PhD No disclosure on file
Rajani Sebastian, PhD No disclosure on file
Jeffrey J. Sevigny, MD Dr. Sevigny has received personal compensation for serving as an employee of Rapport Therapeutics.
Heather Lau, MD Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Aarushi Suneja, MD Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Birgit Surböck, MD No disclosure on file
Charu Ramchandani, MD No disclosure on file
Francesca Rosini, MD No disclosure on file
Ramakrishnan Ramalingam, MD, DM No disclosure on file
Jennifer Vannest No disclosure on file
Janet Benesh, BSMT No disclosure on file
Lenore C. Ocava, MD No disclosure on file
Arnaldo E. Velez, MD No disclosure on file
Coleen Hanlon No disclosure on file
Amanda C. Guidon, MD, MPH An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ - Continuum. The institution of Dr. Guidon has received research support from NINDS. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Guidon has a non-compensated relationship as a Executive Committee Member with Neuromuscular Study Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Patricio Blaya, MD No disclosure on file
Caroline Antoniol, MD No disclosure on file
Nik Haliza Nik Hassan, MD No disclosure on file
Liana Apostolova, MD, FÂ鶹´«Ã½Ó³»­ Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Christopher Goetz, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Shu Leong Ho, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Bashir S. Shihabuddin, MD No disclosure on file
Pavel Klein, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Christopher Schwarz The institution of Christopher Schwarz has received research support from NIH.
Stela Lefter, MD No disclosure on file
Sergi Martinez-Ramirez, MD Dr. Martinez-Ramirez has nothing to disclose.
Sarkis Morales-Vidal, MD Dr. Morales-Vidal has nothing to disclose.
Brian D. Moseley, MD Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
Jerry S. Wolinsky, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Carolina De Jesus-Acosta, MD No disclosure on file
Joon Y. Kang, MD Dr. Kang has nothing to disclose.
Sandeep Kumar, MD Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Basim M. Uthman, MD, FACIP, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Niranjan N. Singh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Singh has nothing to disclose.
Barbara Bumstead, NP Ms. Bumstead has nothing to disclose.
Derrece K. Reid, MD No disclosure on file
Jacquelyn Laplant No disclosure on file
Raquel Gardner, MD Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Mitchel S. Berger, MD No disclosure on file
Marcelo Rocha, MD, PhD The institution of Dr. Rocha has received research support from NIH.
Arayamparambil Anilkumar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Shefali Karkare, MD Dr. Karkare has nothing to disclose.
Simona V. Proteasa, MD Dr. Proteasa has nothing to disclose.
Stella E. Hughes, MD Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Meeting Chair with Merck. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Biogen. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Meeting Chair with Roche. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Conference Delegate with Roche.
Alok Sachdeva, MD No disclosure on file
Bonnie Breining No disclosure on file
Andrea Harriott, MD Dr. Harriott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Orhan H. Akman, PhD No disclosure on file
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Pamela Federighi No disclosure on file
Chester Mathis No disclosure on file
Aiesha Ahmed, MD, MBA, FÂ鶹´«Ã½Ó³»­ Dr. Ahmed has stock in Doximity.
Etienne Laverse, MBBS, BSc, MRCP(Neurol), AICSM Dr. Laverse has nothing to disclose.
Sarita Said-Said, MD, FÂ鶹´«Ã½Ó³»­ Dr. Said-Said has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Gritman Medical Center.
Brendan Cohn-Sheehy, MD, PhD No disclosure on file
Shivnaveen Bains, MD No disclosure on file
Steven Xian, MD No disclosure on file
Glynnis Zieman, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Zieman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Football League.
Claudia Sobreira, MD No disclosure on file
Erum M. Shariff, MBBS, FCPS Dr. Shariff has nothing to disclose.
Matthew Harris Matthew Harris has nothing to disclose.
Srilatha Siripuram No disclosure on file
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Yelena G. Pyatkevich, MD Dr. Pyatkevich has received personal compensation for serving as an employee of Takeda. Dr. Pyatkevich has stock in Takeda.
Brigitte Wildemann, MD The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Bruno Coutinho, MD No disclosure on file
Emanuele Barca, MD, PhD Dr. Barca has nothing to disclose.
Alessandro D'Ambrosio No disclosure on file
Hans Offenbacher, MD Dr. Offenbacher has nothing to disclose.
Thomas Seifert, MD No disclosure on file
Fermina A. Pirmohamed, MD No disclosure on file
Karen D. Orjuela, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Orjuela has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Orjuela has received research support from American Heart Association and Bristol Myers Squibb Foundation.
Alberto J. Espay, MD, FÂ鶹´«Ã½Ó³»­ Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Jean Baptiste Chanson No disclosure on file
Minjee Kim, MD The institution of Dr. Kim has received research support from Genentech, Inc.. The institution of Dr. Kim has received research support from National Institute on Aging.
Perry K. Richardson, MD Dr. Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedForce.
Justin T. Mhoon, MD No disclosure on file
Maromi Nei, MD No disclosure on file
Robert P. Rubens, MD, MBA, FÂ鶹´«Ã½Ó³»­ Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Shilpi Mittal, MD Dr. Mittal has nothing to disclose.
Lisa Meng No disclosure on file
Mathieu Anheim No disclosure on file
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
William B. Young, MD, FÂ鶹´«Ã½Ó³»­ Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Tanya J. Lehky, MD Dr. Lehky has nothing to disclose.
Terrie Livingston, PharmD Ms. Livingston has received personal compensation for serving as an employee of Octave Bioscience. Ms. Livingston has received personal compensation for serving as an employee of EMD Serono. Ms. Livingston has or had stock in Biogen.Ms. Livingston has or had stock in Octave Bioscience.Ms. Livingston has a non-compensated relationship as a Board of Directors with MSAA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Christopher J. Boes, MD, FÂ鶹´«Ã½Ó³»­ Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Gonzalo Revuelta, DO The institution of Dr. Revuelta has received research support from NIH.
Lyell K. Jones, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with Â鶹´«Ã½Ó³»­. Dr. Jones has a non-compensated relationship as a member of the Â鶹´«Ã½Ó³»­ Board of Directors with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Morris H. Scantlebury, MD No disclosure on file
Ann Ligocki No disclosure on file
Luigi Lavorgna No disclosure on file
Thyagarajan Subramanian, MD, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Department of Defense . Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
Licia Grazzi, MD Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Nitin Tandon Nitin Tandon has stock in BrainDynamics. The institution of Nitin Tandon has received research support from NIH.
Serge Khelemsky, DO No disclosure on file
Konrad Rejdak, PhD Dr. Rejdak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda. Dr. Rejdak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda.
Michael D. Perloff, MD, PhD Dr. Perloff has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for several law firms/Universities.
Gianna Carla Riccitelli No disclosure on file
Antonio Federico, MD, Prof No disclosure on file
Allen J. Aksamit, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Aksamit has nothing to disclose.
Marwan N. Sabbagh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Brett L. Cucchiara, MD Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elseiver. Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bayer. Dr. Cucchiara has received publishing royalties from a publication relating to health care.
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FANA, FÂ鶹´«Ã½Ó³»­ Dr. Ramachandiran has nothing to disclose.
Jacob S. Elkins, MD No disclosure on file
Yael Nissan No disclosure on file
Nolan Williams, MD No disclosure on file
James P. Klaas, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Klaas has received publishing royalties from a publication relating to health care.
Manuela De Stefano No disclosure on file
Maria Petracca, PhD Dr. Petracca has nothing to disclose.
Jessica Wilcox, MD Dr. Wilcox has nothing to disclose.
Adam Rizvi, MD No disclosure on file
Danielle B. Pier, MD No disclosure on file
Sahil Gupta, MD Dr. Gupta has nothing to disclose.
Klemens Winder, MD No disclosure on file
Suhail Al-Shammri, FRCPC, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ayush Batra, MD Dr. Batra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Batra has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogenerator Ventures. Dr. Batra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. The institution of Dr. Batra has received research support from GeNeuro SA. The institution of Dr. Batra has received research support from National Institutes of Health. Dr. Batra has received publishing royalties from a publication relating to health care.
Marilyn J. McKasson, MD No disclosure on file
Vikram Shivkumar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Qinyi Jiang No disclosure on file
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Lydia Sharp, MD The institution of Dr. Sharp has received research support from McNair Foundation. The institution of Dr. Sharp has received research support from ALS Association.
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Anand Viswanathan, MD Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Kym Boycott No disclosure on file
Olimpia Musumeci No disclosure on file
Melissa Sorosina Melissa Sorosina has received research support from Italian Multiple Sclerosis Foundation. Melissa Sorosina has received research support from Italian Ministry of Health.
Harpreet Kaur, MD No disclosure on file
Nikolaos I. Papamitsakis, MD The institution of Dr. Papamitsakis has received research support from AHA.
Robert Kahoud No disclosure on file
Channaiah Srikanth Mysore No disclosure on file
Sonia N. Krish, MD No disclosure on file
Victoria Barghout, PhD No disclosure on file
Christian Ritter, MD No disclosure on file
Dong Joo Yun No disclosure on file
Yuen Kwun Wong No disclosure on file
Chang Shek Kwan, MD Dr. Kwan has nothing to disclose.
Ankit Pahwa Ankit Pahwa has nothing to disclose.
Anne E. Bunner, PhD No disclosure on file
David Miller No disclosure on file
Jithin S. George, MD No disclosure on file
Josiane LaJoie, MD Dr. LaJoie has nothing to disclose.
Kasra Maasumi, MD No disclosure on file
Ken Myers, MD, PhD Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AS2Bio. The institution of Dr. Myers has received research support from Fonds de Recherche de Santé Québec. The institution of Dr. Myers has received research support from Liam Foundation. The institution of Dr. Myers has received research support from Pediatric Research Foundation. The institution of Dr. Myers has received research support from Montreal Children's Hospital Foundation. The institution of Dr. Myers has received research support from CQDM/Pharma Liam. The institution of Dr. Myers has received research support from CIHR.
Marcelo Mattiazzi, MD No disclosure on file
Joseph Maytal, MD No disclosure on file
Isabella L. Simone No disclosure on file
Marcio L. Balthazar, MD, PhD No disclosure on file
Silvia Messina No disclosure on file
Aaron Schultz No disclosure on file
Jodi W. Chardon No disclosure on file
Adnan Subei, DO, FÂ鶹´«Ã½Ó³»­ Dr. Subei has received personal compensation for serving as an employee of Neurology Consultants of Dallas. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Efficient. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Meyer Squibb. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Subei has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Subei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Jamie L. Starks, MD Dr. Starks has nothing to disclose.
Sarah Stone, MD No disclosure on file
Joao D. Farinhas, MD No disclosure on file
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Eliahu Heldman, PhD No disclosure on file
Irwin Hollander, PhD No disclosure on file
Ju-Young Na No disclosure on file
Scott J. Koenig, Jr. No disclosure on file
Juergen Haas Juergen Haas has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Melissa L. Rayhill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Â鶹´«Ã½Ó³»­.
Julie Price No disclosure on file
Lucas D. Branco No disclosure on file
Leopold J. Streletz, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Jamie H. Campbell, MD Dr. Campbell has nothing to disclose.
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Thomas Mathew, MD Dr. Mathew has nothing to disclose.
Ludger Schols, MD Dr. Schols has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VICO Therapeutics. Dr. Schols has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schols has received research support from Vigil.
Jose M. Chaves No disclosure on file
Matthis Synofzik Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Paola Valsasina Paola Valsasina has nothing to disclose.
Allan H. Ropper, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Natarajan Visvanathan, MD, DM, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ritesh Ramdhani, MD Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encora Therapeutics. Dr. Ramdhani has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Encora Therapeutics. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance. Dr. Ramdhani has received intellectual property interests from a discovery or technology relating to health care.
Eric S. Fulmer No disclosure on file
Matteo Pardini, MD, PhD No disclosure on file
Masoud Majed, MD Dr. Majed has nothing to disclose.
Mario Zappia, MD No disclosure on file
Fethi Idiman, MD No disclosure on file
Jongyeol Kim, MD, MS, RPVI, RPNI, RVT, NVS Dr. Kim has nothing to disclose.
Walter O. Arruda, MD, PhD Dr. Arruda has nothing to disclose.
John W. Rose, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Maria Buccafusca No disclosure on file
Rebecca B. Williams No disclosure on file
Andre P. Matta, MD Dr. Matta has received personal compensation for serving as an employee of Sanofi. Dr. Matta has received stock or an ownership interest from Sanofi.
Thibault Moreau Thibault Moreau has nothing to disclose.
Johanne Somme, PhD No disclosure on file
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Alireza Zandifar, MD Dr. Zandifar has nothing to disclose.
Nestor A. Estevez, MD No disclosure on file
Ingrid van der Mei No disclosure on file
Javier A. Rolle, MD No disclosure on file
Asli Koskderelioglu No disclosure on file
Yael Reijmer No disclosure on file
Zuzana Nedelska, MD, PhD No disclosure on file
Gary K. Lau, MBBS Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Lau has stock in ReMobility. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care.
Anindita Deb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Raul De La Fuente-Fernandez, MD No disclosure on file
Eduardo R. Davidovich Dr. Davidovich has nothing to disclose.
Luis E. Bello-Espinosa, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bello-Espinosa has nothing to disclose.
Sasikanth Gorantla, MD Dr. Gorantla has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for OSF HealthCare. Dr. Gorantla has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Sleep Medicine.
Salil Soman, MD No disclosure on file
Karen Morgenshtern, MD No disclosure on file
Richard L. Yates No disclosure on file
Damiano Paolicelli Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Benjamin R. Claytor, MD Dr. Claytor has nothing to disclose.
Brian Sansoucy No disclosure on file
Yadira Velazquez-Rodriguez, MD No disclosure on file
Argye E. Hillis, MD, MA Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Owen A. Ross, PhD Dr. Ross has nothing to disclose.
Gabriel Persi Gabriel Persi has nothing to disclose.
Rodney O. Leacock, MD, FÂ鶹´«Ã½Ó³»­ Dr. Leacock has nothing to disclose.
Virginia Laura Parisi, MD No disclosure on file
Sharon Stoll, DO Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for roche Genentech. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi/genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Stoll has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Stoll has stock in BeCare Link LLC. Dr. Stoll has stock in Global Consult MS .
Naresh Mullaguri, MD Dr. Mullaguri has nothing to disclose.
Albert E. Kim, MD No disclosure on file
Justin Y. Kwan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Morris Freedman, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Horacio C. Kaufmann, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Lines Vargas Collado, MD No disclosure on file
Amna Sohail, MD Dr. Sohail has nothing to disclose.
Jennifer R. Molano, MD, FÂ鶹´«Ã½Ó³»­ Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Tara Kimbason, MD, MPH No disclosure on file
Jun-ichi Satoh, MD, PhD No disclosure on file
Divpreet Kaur, MD No disclosure on file
Alessandra Rufa, MD, PhD No disclosure on file
Filippo Martinelli Boneschi No disclosure on file
Facundo Manes No disclosure on file
Ilja Bobylev No disclosure on file
Claire Modica An immediate family member of Claire Modica has received personal compensation for serving as an employee of Thermo Fisher Scientific. The institution of Claire Modica has received research support from Congressionally Directed Medical Research Programs. The institution of Claire Modica has received research support from Office of Naval Research.
Gosala R. Sarma, MD No disclosure on file
Robert L. Knobler, MD, PhD No disclosure on file
Iryna Lobanova, MD, PhD Iryna Lobanova has nothing to disclose.
Claudio Gobbi, MD Dr. Gobbi has nothing to disclose.
Giuseppe Salemi, MD No disclosure on file
E. M. Hoffman, DO, PhD Dr. Hoffman has nothing to disclose.
Alex Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Nelson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Lakeview Hospital. Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medical Consultants Network. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dane Street. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for ExamWorks.
Gabriella Coniglio, MD No disclosure on file
Camila C. Piccinin, MD Dr. Piccinin has nothing to disclose.
Felix Bermejo-Pareja, MD No disclosure on file
Tyler Webb, MD No disclosure on file
Mark S. George, MD No disclosure on file
Sylvia A. Mohen, MD No disclosure on file
Fulton Velez No disclosure on file
Anna E. Blanken Ms. Blanken has nothing to disclose.
M.T. Dotti, MD No disclosure on file
Alvino Bisecco Alvino Bisecco has nothing to disclose.
Benjamin Kay, MD No disclosure on file
Jean-Marc Leger, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Sigurlaug Sveinbjornsdottir No disclosure on file
Adriano Chio, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Jennifer Harney No disclosure on file
Luisa Vuolo No disclosure on file
Noah Benson No disclosure on file
Seok Kim No disclosure on file
Ercan Karabacak No disclosure on file
Jeffrey D. Bernstein No disclosure on file
Stephan Goedee, MD No disclosure on file
Rahul Desikan No disclosure on file
Simona Bonavita No disclosure on file
Jennifer R. Miller No disclosure on file
Andrew G. Herzog, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Herzog has nothing to disclose.
Anneliese Radke No disclosure on file
Eleanor Sung No disclosure on file
Shilpa Kolli No disclosure on file
Ana Rodriguez Regal Ana Rodriguez Regal has nothing to disclose.
Alyssa Brandt No disclosure on file
Kandiah Nagaendran No disclosure on file
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Rahul Khanna, MBBS Dr. Khanna has nothing to disclose.
Brian Kopell No disclosure on file
Matthieu Bereau Matthieu Bereau has nothing to disclose.
Maria K. Storch, MD No disclosure on file
Katherine Agoropoulou, PhD No disclosure on file
Kaylan Burnham No disclosure on file
Maria Gaitan, MD Dr. Gaitan has nothing to disclose.
Gadi Miron No disclosure on file
Gloria Kim No disclosure on file
Declan T. Chard No disclosure on file
Jorge O. Norscini, MD No disclosure on file
Lobo M. Alexander, MD, DM No disclosure on file
Enrique L. Aradillas, MD No disclosure on file
Maria O. Chavez, MD Dr. Chavez has nothing to disclose.
Lee H. Schwamm, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime Â鶹´«Ã½Ó³»­. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Mary Vo, MD Dr. Vo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vo has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Phillips and Paolicchi.
Ayman P. Tourbah No disclosure on file
Michael Hossack, MD Dr. Hossack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rivanna.
Karen Berman, MD No disclosure on file
Helen Barkan, MD, PhD No disclosure on file
David R. Busch, PhD No disclosure on file
Jennifer Morganroth, MD, MBA Dr. Morganroth has nothing to disclose.
Sedeek A. Elmoursi, MD No disclosure on file
Kamalini G. Ranasinghe, MD, PhD Dr. Ranasinghe has nothing to disclose.
Valerie Brachet, PhD Dr. Brachet has received personal compensation for serving as an employee of Fluxus inc..
Roy E. Strowd III, MD, FÂ鶹´«Ã½Ó³»­ Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Malgorzata Jaremko, PhD No disclosure on file
Mustafa Kendirli Dr. Kendirli has nothing to disclose.
Sebastian Camerlingo No disclosure on file
Jay E. Selman, MD No disclosure on file
Molly Zimmerman No disclosure on file
Gabriele C. De Luca, MD, DPhil, FRCPath, FÂ鶹´«Ã½Ó³»­ Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wellcome Trust. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from Rosetrees Trust. The institution of Dr. De Luca has received research support from Strategic Innovation Fund, Oxford University. The institution of Dr. De Luca has received research support from Agence National de la Recherche. Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Continuum (Â鶹´«Ã½Ó³»­) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Frontiers in Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Paul L. Durham, PhD No disclosure on file
William Boles, MD Dr. Boles has nothing to disclose.
Ellen Campbell, MD MB BCh BAO MRCP No disclosure on file
Dara M. West, MD No disclosure on file
Alice J. Schabas, MD Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Claudio M. De Gusmao, MD Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mendelics Genomic Analysis. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving as a Consultant for EBSCO publishing. Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Outcome Solutions. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeuthics. The institution of Dr. DeGusmao has received research support from FDA.
Frank Andrasik No disclosure on file
Michel G. Clanet, Prof No disclosure on file
Michelle L. Mellion, MD Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Krai Chatamra, PhD No disclosure on file
Richard Wise No disclosure on file
Christopher Scherfler, MD No disclosure on file
Mei-Sheng Duh, MPH, ScD No disclosure on file
Petra Nytrova No disclosure on file
Wendy Chen, MD Dr. Chen has nothing to disclose.
Eric J. Pappert, MD No disclosure on file
Demetrius M. Maraganore, MD, FÂ鶹´«Ã½Ó³»­ Dr. Maraganore has nothing to disclose.
Carlos Silvado, MD No disclosure on file
Alfred W. Sandrock, MD, PhD No disclosure on file
Serge G. Gauthier, MD Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
Mark Edwards, MBBS Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Edwards has stock in Brain and Mind Ltd. The institution of Dr. Edwards has received research support from NIHR. Dr. Edwards has received publishing royalties from a publication relating to health care.
Joao O. Siffert, MD No disclosure on file
Luisa Maria Villar Guimerans, MD No disclosure on file
Josep Gamez, MD, PhD The institution of Dr. Gamez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Gamez has received research support from Government of Spain (FIS FEDER).
Walter R. Royal III, MD No disclosure on file
Donna L. Masterman, MD Dr. Masterman has received personal compensation for serving as an employee of Prothena Biosciences . Dr. Masterman has stock in Prothena Biosciences.
Joerg Windsheimer, MD No disclosure on file
Pascal Maisonobe Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Gilbert R. Gonzales, MD No disclosure on file
Kathryn A. Giles, MD No disclosure on file
Nicholas D. Lawn, FRACP, MBCHB Dr. Lawn has nothing to disclose.
Sanjay Gandhi, MD Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Richard A. Macdonell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Macdonell has nothing to disclose.
Jimmy A. Schiemann No disclosure on file
Cinzia Cordioli, MD Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Deborah Reed, MD No disclosure on file
Hideki Garren, MD, PhD Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.
Stefan Braune Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Claire E. Carrazco, DO No disclosure on file
Guido Sabatella Guido Sabatella has received personal compensation for serving as an employee of Alexion.
James G. Yarger, CEO No disclosure on file
Robert Lenz, MD No disclosure on file
Marilyn R. Semenchuk, PharmD, MSc No disclosure on file
Nicholas Boulis Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sio Gene Therapy. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CODA Bio. Nicholas Boulis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gibbs Attorneys. Nicholas Boulis has received stock or an ownership interest from Curative. Nicholas Boulis has received stock or an ownership interest from Remotor. The institution of Nicholas Boulis has received research support from NIH. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received publishing royalties from a publication relating to health care.
LECIO FIGUEIRA PINTO, MD No disclosure on file
Michel Gillard, PhD No disclosure on file
Lindsay R. Chura, PhD No disclosure on file
Andreas Lysandropoulos Andreas Lysandropoulos has nothing to disclose.
Feride H. Frech, PhD Dr. Frech has received personal compensation for serving as an employee of Eisai Inc.
Roshan L. Koul, MD, DM, FRCPCH No disclosure on file
Matthew Farrer, PhD No disclosure on file
Vivay Peter Misra, MD No disclosure on file
Savary Om No disclosure on file
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Dimitri M. Kullmann No disclosure on file
Edward Firouztale, DO, DSc, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Erica Selheimer, MD No disclosure on file
Paulo P. Fontoura, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Anyzeila Diaz, PharmD No disclosure on file
Paul Lingor, MD No disclosure on file
Martin Nevrly, MD No disclosure on file
Simon Borghs No disclosure on file
Wolfgang Heide, MD, FEAN No disclosure on file
Francisco Zagmutt No disclosure on file
Nicholas J. Everage No disclosure on file
Nadia B. Ben Ali, PhD No disclosure on file
Augusto Grinspan, MD Dr. Grinspan has received personal compensation for serving as an employee of Insightec.
Sonia Khan No disclosure on file
Jaclyn B. Caccese, PhD No disclosure on file
Eric Swayze, PhD No disclosure on file
Evelyn Olson No disclosure on file
Monica Margoni Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Xiaolan Ye, PhD No disclosure on file
Matthew Klein Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care.
Frederic Sedel No disclosure on file
John Ko, PharmD, MS Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Niamh Murphy No disclosure on file
Dimitri Guala No disclosure on file
Eugene M. Gan No disclosure on file
Steven H. Nye, PhD No disclosure on file
Ying Wu No disclosure on file
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Yan Ling No disclosure on file
Claudia Prada No disclosure on file
Ying Liu No disclosure on file
Peter McCroskery No disclosure on file
Nicola De Rossi Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Audra Boscoe No disclosure on file
Julie Moberg No disclosure on file
RJ Wirth, PhD RJ Wirth has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.